Skin Cancer Under Special Circumstances

  • M. Ulrich
  • C. Ulrich
  • Anja V. Potthoff
  • Norbert H. Brockmeyer
  • Competence Network for HIV/AIDS Germany
  • G. Schäfer-Hesterberg
  • Theodore Rosen
  • Robert Baran
  • Kenneth W. NealJr
  • Hugh M. GlosterJr

Core Messages

  • Skin cancer is the most common neoplasm in organ transplant recipients (OTR)

  • Actinic keratosis and squmous cell carcinoma represent the most common malignant skin tumour in OTR

  • Risk factor include increased age at time of transplantation, chronic sun-exposure, skin type and immunosuppressive medication (type, duration, level/dosage)

  • Sunprotection including the use of highly protective sunscreen is very important and represents the basis of management

  • Interdisciplinary management and close collaboration with transplant physicians is necessary which include the optimization of immunosuppressive medication


Squamous Cell Carcinoma Skin Cancer Human Papilloma Virus Basal Cell Carcinoma Merkel Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Kasiske BL, Snyder JJ, Gilbertson et al (2004) Cancer after kidney transplantation in the United States. Am J Transplant 4(6):905–913PubMedCrossRefGoogle Scholar
  2. 2.
    Jensen P, Hansen S, Moller B et al (1999) Skin cancer in kidney and heart transplant recipients and different longterm immunosuppressive therapy regimens. J Am Acad Dermatol 40(2 Pt 1):177–186PubMedCrossRefGoogle Scholar
  3. 3.
    Lindelöf B, Sigurgeirsson H, Gäbel et al (2000) Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 143(3):513–519PubMedGoogle Scholar
  4. 4.
    Ramsay HM, Fryer AA, Hawley CM et al (2002) Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol 147(5):950–956PubMedCrossRefGoogle Scholar
  5. 5.
    O'Donovan P, Perrett CM, Zhang X et al (2005) Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 309(5742):1871–1874PubMedCrossRefGoogle Scholar
  6. 6.
    Guba M, von Breitenbuch P, Steinbauer M et al (2002) Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 8(2):128–135PubMedCrossRefGoogle Scholar
  7. 7.
    Yarosh DB, Boumakis S, Brown AB et al (2002) Measurement of UVB-Induced DNA damage and its consequences in models of immunosuppression. Methods 28(1):55–62PubMedCrossRefGoogle Scholar
  8. 8.
    Koehl GE, Gaumann A, Zuelke C et al (2006) Development of de novo cancer in p53 knock-out mice is dependent on the type of long-term immunosuppression used. Transplantation 82(6):741–748PubMedCrossRefGoogle Scholar
  9. 9.
    Kahan BD, Yakupoglu YK, Schoenberg L et al (2005) Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients. Transplantation 80(6): 749–758PubMedCrossRefGoogle Scholar
  10. 10.
    Nindl I, Gottschling M, Stockfleth E (2007) Human papil-lomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis Markers 23(4):247–259PubMedGoogle Scholar
  11. 11.
    Euvrard S, Kanitakis J, Decullier E et al (2006) Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 81(8): 1093–1100PubMedCrossRefGoogle Scholar
  12. 12.
    Stasko T, Brown MD, Carucci JA et al (2004) Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 30(4 Pt 2):642–650PubMedCrossRefGoogle Scholar
  13. 13.
    Ackerman AB (2003) Solar keratosis is squamous cell carcinoma. Arch Dermatol 139(9):1216–1217PubMedCrossRefGoogle Scholar
  14. 14.
    Braakhuis BJ, Tabor MP, Kummer JA et al (2003) A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63(8):1727–1730PubMedGoogle Scholar
  15. 15.
    Barr BB, Benton EC, McLaren K et al (1989) Papillomavirus infection and skin cancer in renal allograft recipients. Lancet 2(8656):224–225PubMedCrossRefGoogle Scholar
  16. 16.
    Dragieva G, Hafner J, Dummer R et al (2004) Topical pho-todynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 77(1):115–121PubMedCrossRefGoogle Scholar
  17. 17.
    Ulrich C, Bichel J, Euvrard S et al (2007) Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and effi-cacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. Br J Dermatol 157(Suppl 2):25–31PubMedCrossRefGoogle Scholar
  18. 18.
    Ulrich C, Hackethal M, Ulrich M et al (2007) Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases. Br J Dermatol 156(Suppl 3):40–42PubMedCrossRefGoogle Scholar
  19. 19.
    Hartevelt MM, Bavinck JN, Kootte AM et al (1990) Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 49(3):506–509PubMedCrossRefGoogle Scholar
  20. 20.
    Kanitakis J, Alhaj-Ibrahim L, Euvrard S et al (2003) Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases. Arch Dermatol 139(9):1133–1137PubMedCrossRefGoogle Scholar
  21. 21.
    Buell JF, Trofe J, Hanaway MJ et al (2002) Immunosuppression and Merkel cell cancer. Transplant Proc 34(5):1780–1781PubMedCrossRefGoogle Scholar
  22. 22.
    Moloney FJ, Comber H, O'Lorcain P et al (2006) A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 154(3):498–504PubMedCrossRefGoogle Scholar
  23. 23.
    Brown VL, Matin RN, Cerio R et al (2007) Melanomas in renal transplant recipients: the London experience, and invitation to participate in a European study. Br J Dermatol 156(1):165–167PubMedCrossRefGoogle Scholar
  24. 24.
    Le Mire L, Hollowood K, Gray D et al (2006) Melanomas in renal transplant recipients. Br J Dermatol 154(3):472–477PubMedCrossRefGoogle Scholar
  25. 25.
    Bastiaannet E, Homan-van der Heide JJ, Ploeg RJ et al (2007) No increase of melanoma after kidney transplantation in the northern part of The Netherlands. Melanoma Res 17(6):349–353PubMedCrossRefGoogle Scholar
  26. 26.
    Penn I (1996) Malignant melanoma in organ allograft recipients. Transplantation 61(2):274–278PubMedCrossRefGoogle Scholar
  27. 27.
    Penn I (1998) De novo malignances in pediatric organ transplant recipients. Pediatr Transplant 2(1):56–63PubMedGoogle Scholar
  28. 28.
    Greene MH, Young TI, Clark WH Jr (1981) Malignant melanoma in renal-transplant recipients. Lancet 1(8231):1196–1199PubMedCrossRefGoogle Scholar
  29. 29.
    Dinh QQ, Chong AH (2007) Melanoma in organ transplant recipients: the old enemy finds a new battleground. Australas J Dermatol 48(4):199–207PubMedCrossRefGoogle Scholar
  30. 30.
    Otley CC, Hirose R, Salasche SJ (2005) Skin cancer as a contraindication to organ transplantation. Am J Transplant 5(9):2079–2084PubMedCrossRefGoogle Scholar
  31. 31.
    Penn I (1997) Transmission of cancer from organ donors. Ann Transplant 2(4):7–12PubMedGoogle Scholar
  32. 32.
    Stephens JK, Everson GT, Elliott CL et al (2000) Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation 70(1):232–236PubMedGoogle Scholar
  33. 33.
    Morris-Stiff G, Steel A, Savage P et al (2004) Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant 4(3):444–446PubMedCrossRefGoogle Scholar
  34. 34.
    Serraino D, Angeletti C, Carrieri MP et al (2005) Kaposi's sarcoma in transplant and HIV-infected patients: an epide-miologic study in Italy and France. Transplantation 80(12): 1699–1704PubMedCrossRefGoogle Scholar
  35. 35.
    Francès C, Mouquet C, Marcelin AG et al (2000) Outcome of kidney transplant recipients with previous human herpes-virus-8 infection. Transplantation 69(9):1776–1779PubMedCrossRefGoogle Scholar
  36. 36.
    Cattaneo D, Gotti E, Perico N et al (2005) Cyclosporine formulation and Kaposi's sarcoma after renal transplantation. Transplantation 80(6):743–748PubMedCrossRefGoogle Scholar
  37. 37.
    Campistol JM, Schena FP (2007) Kaposi's sarcoma in renal transplant recipients — the impact of proliferation signal inhibitors. Nephrol Dial Transplant 22(Suppl 1):i17–22PubMedCrossRefGoogle Scholar
  38. 38.
    Ulrich C, Degen A, Patel MJ et al (2008) Sunscreens in organ transplant patients. Nephrol Dial Transplant 23:1805–1808PubMedCrossRefGoogle Scholar
  39. 39.
    Ulrich C, Jürgensen JS, Degen A, Hackethal M, Ulrich M, Patel MJ, Eberle J, Terhorst D, Sterry W, Stockfleth E. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.HYPERLINK “javascript:AL_get(this, ‘jour’, ‘Br J Dermatol.’);”Br J Dermatol. 2009 Nov;161 Suppl 3:78–84PubMedCrossRefGoogle Scholar
  40. 1.
    Penn I (2000) Cancers in renal transplant recipients. Adv Ren Replace Ther 7:147–156PubMedGoogle Scholar
  41. 2.
    Dalgleish AG, O'Byrne KJ (2002) Chronic immune activation and infl ammation in the pathogenesis of AIDS and cancer. Adv Cancer Res 84:231–276PubMedCrossRefGoogle Scholar
  42. 3.
    Bonnet F, Lewden C, May T et al (2004) Malignancy-related causes of death in human immunodefi ciency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 101:317–324PubMedCrossRefGoogle Scholar
  43. 4.
    Nadal SR, Calore EE, Manzione CR et al (2005) Hypertrophic herpes simplex simultating anal neoplasia in AIDS patients: report of fi ve cases. Dis Colon Rectum. 48:2289–2293PubMedCrossRefGoogle Scholar
  44. 5.
    Rabkin CS, Goedert J, Biggar RJ et al (1990) Kaposi's sarcoma in three HIV-1-infected cohorts. J Acquir Immune Defic Syndr 3(Suppl1):38–43Google Scholar
  45. 6.
    Rasokat H, Haussermann L, Minnemann M (1989) Response of AIDS-related Kaposi's sarcoma to treatment with recombinant interferon alpha depends on the stage of underlying immunodefi ciency. J Invest Dermatol 89:444–445Google Scholar
  46. 7.
    Sullivan R, Dezube BJ, Koon HB (2007) Signal transduction targets in Kaposi's sarcoma. Curr Opin Oncol 18:456–462CrossRefGoogle Scholar
  47. 8.
    Brockmeyer NH, Willers CP, Anders S et al (1999) Cytokine profi le of HIV-positive Kaposi's sarcoma derived cells in vitro. Eur J Med Res 4:95–100PubMedGoogle Scholar
  48. 9.
    Brockmeyer NH, Barthel B (1998) Clinical manifestations and therapies of AIDS associated tumors. Eur J Med Res 3:127–147PubMedGoogle Scholar
  49. 10.
    Krown SE, Metroka C, Wernz JC (1989) Kaposi's sarcoma in the acquired immune defi ciency syndrome: a proposal for uniform evaluation, response and staging criteria. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 7:1201–1207PubMedGoogle Scholar
  50. 11.
    Schöfer H, Brockmeyer NH (2006) Brief guidelines-Kaposi's sarcoma. JDDG 4:586–950PubMedCrossRefGoogle Scholar
  51. 12.
    Maserati R et al (2000) Effects of HAART Regimen as exclusive treatment of Slow Proliferating Kaposi's Sarcoma. Int Conf AIDS 13:Abstract no TuOrB302Google Scholar
  52. 13.
    Sgadari C, Barillari G, Toschi E et al (2002) HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi's sarcoma. Nat Med 8:225–232PubMedCrossRefGoogle Scholar
  53. 14.
    Leidner RS, Aboulafia DM (2005) Recrudescent Kaposi's sarcoma after initiation of HAART-a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS 19:635–644PubMedCrossRefGoogle Scholar
  54. 15.
    Schöfer H, Ochsendorf FR, Hochscheid I, Mulbradt R (1991) Kaposi-Sarkome im Gesicht: Palliative Behandlung mit Kryochirurgie, intraläsionaler Chemotherapie, Röntgenweichstrahltherapie und Camoufl age. Hautarzt 42:492–498PubMedGoogle Scholar
  55. 16.
    Morganroth GS (2002) Topical 0.1% alitretinoin gel for classic Kaposi sarcoma. Arch Dermatol 138:542–543PubMedCrossRefGoogle Scholar
  56. 17.
    Stelzer KJ, Griffin TW (1993) A randomized prospective trial of radiation therapy for AIDS-associated Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 27:1057–1061PubMedCrossRefGoogle Scholar
  57. 18.
    Krown SE, Li P, Von Roenn JH et al (2002) Effi cacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study. J Interferon Cytokine Res 22:295–303PubMedCrossRefGoogle Scholar
  58. 19.
    Goebel FD, Jablonowski H (1999) Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma-offi cial satellite to the 7th European Confer ence on Clinical Aspects and Treatment of HIV-infection. 23 October 1999 in Lisbon, Portugal. Eur J Res 4:507–513Google Scholar
  59. 20.
    Cooley T, Henry D, Tonda M et al (2007) A randomized, double-blind study of pegylated liposomal doxorubicin fort he treatment of AIDS-related Kaposi's sarcoma. Oncologist 12:114–123PubMedCrossRefGoogle Scholar
  60. 21.
    Lichterfeld M, Qurishi N, Hoffmann C et al (2004) Treatment of HIV-1-associated Kaposi's sarcoma with pegylated lipo-somal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery. Infection 33:140–147CrossRefGoogle Scholar
  61. 22.
    Osoba D, Northfelt DW, Budd DW, Himmelberger D (2001) Effect of treatment on health-related quality of life in acquired immunodefi ciency syndrom (AIDS)-related Kaposi's sarcoma: a randomized trial of pegylated liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine. Cancer Invest 19:573–580PubMedCrossRefGoogle Scholar
  62. 23.
    Stewart S, Jablonowski H, Goebel FD et al (1998) Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal doxorubicin Study Group. J Clin Oncol 16:683–691PubMedGoogle Scholar
  63. 24.
    Lorusso D, Di Stefano A, Carone V et al (2007) Pegylated liposomal doxorubicin-related palmar-plantar erythrodyses-thesia (‘hand-foot’syndrome). Ann Oncol 18:1159–1164PubMedCrossRefGoogle Scholar
  64. 25.
    Tulpule A, Groopman J, Saville MW et al (2002) Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi's sarcoma. Cancer 95:147–154PubMedCrossRefGoogle Scholar
  65. 26.
    Campistol JM, Schna FP (2007) Kaposi's sarcoma in renal transplant recipients –the impact of proliferation signal inhibitors. Nephrol Dial Transplant 22 Suppl 1:i17–22PubMedCrossRefGoogle Scholar
  66. 27.
    Brown HJ, Mc Bride WH, Zack JA Sun R (2005) Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus. Antivir Ther 10:745–751PubMedGoogle Scholar
  67. 28.
    Koon HB, Bubley GJ, Pantanowitz L et al (2005) Imatinib-induced regression of AIDS-related Kaposi's sarcoma. J Clin Oncol 23:982–989PubMedCrossRefGoogle Scholar
  68. 29.
    Peng B, Lloyd P, Schran H (2005) Clinical pharmacokinetics of imatinib. Clin Pharmacokinet 44:879–894PubMedCrossRefGoogle Scholar
  69. 30.
    Dezube BJ, Krown SE, Lee JY, Bauer KS, Aboulafia DM (2006) Randomized Phase II Trial of matrix metalloprote-iase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS malignancy consortium study. J Clin Oncol 24:1389–1394PubMedCrossRefGoogle Scholar
  70. 31.
    Breen EC, Boscardin WJ, Detels R et al (2003) Non-Hodgkin's B cell lymphoma in persons with acquired immu-nodefi ciency syndrome is associated with increased serum levels of IL10, or the IL10 promoter 592 C/C genotype. Clin Immunol 10:119–129CrossRefGoogle Scholar
  71. 32.
    Popovic M, Tenner-Racz K, Pelser C et al (2005) Persitence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Sci USA 102:14807–14812CrossRefGoogle Scholar
  72. 33.
    Kerschmann RL, Berger TG, Weiss LM et al (1995) Cutaneous presentations of lymphoma in human immunode-fi ciency virus disease. Predominance of T cell lineage. Arch Dermatol 131:1281–1288PubMedCrossRefGoogle Scholar
  73. 34.
    Macgrogan G, Vergier B, Dubus P et al (1996) CD30-positive cutaneous large cell lymphomas. A comparative study of clinicopathologic and molecular features of 16 cases. Am J Clin Pathol 105:440–450PubMedGoogle Scholar
  74. 35.
    Ezzat H, Filipenko D, Vickars L et al (2007) Improved survival in HIV-associated diffuse large B-cell lympoma with the addition of Rituximab to chemotherapy in patients receiving highly active antiretroviral therapy. HIV Clin Trials 8:132–144PubMedCrossRefGoogle Scholar
  75. 36.
    Kaplan LD, Lee JY, Ambinder RF et al (2005) Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood 106:15–43CrossRefGoogle Scholar
  76. 37.
    Munoz N, Bosch FX, de Sanjose S et al (2003) International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: epidemiologic classifi cation of human papil-lomavirus types associated with cervical cancer. N Engl J Med 348:518–527PubMedCrossRefGoogle Scholar
  77. 38.
    Castellsague X, Diaz M, de Sanjose S et al (2006) International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Worldwide human papillo-mavirus etiology of cervical adenocarcinoma and its cofac-tors: implications for screening and prevention. J Natl Cancer Inst 98:303–315PubMedCrossRefGoogle Scholar
  78. 39.
    Frisch M, Biggar RJ, Goedert JJ (2000) Human papillomavi-rus-associated cancers in patients with human immunodefi -ciency virus infection and acquired immunodefi ciency syndrome. J Natl Cancer Inst 92:1500–1510PubMedCrossRefGoogle Scholar
  79. 40.
    Chin-Hong PV, Vittinghoff E, Cranston RD (2005) Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst 97:896–905PubMedCrossRefGoogle Scholar
  80. 41.
    Kreuter A, Brockmeyer NH, Hochdorfer B et al (2005) Clinical spectrum and virologic characteristics of anal intra-epithelial neoplasia in HIV infection. J Am Acad Dermatol 52:603–608PubMedCrossRefGoogle Scholar
  81. 42.
    Palefsky JM, Holly EA, Efirdc JT et al (2005) Anal intraepi-thelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 19:1407–1414PubMedCrossRefGoogle Scholar
  82. 43.
    Cusini M, Salmaso F. Zerboni R et al (2004) 5% imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy. Int J STD AIDS 15:17–20PubMedCrossRefGoogle Scholar
  83. 44.
    Abbasakoor F, Boulos PB (2005) Anal intraepithelial neo-plasia. Br J Surg 92:277–290PubMedCrossRefGoogle Scholar
  84. 45.
    Wieland U, Brockmeyer NH, Weisenborn SJ (2006) Imiquimod treatment of anal Intraepithelial neoplasia in HIV positive men. Arch Dermatol 142:1430–44CrossRefGoogle Scholar
  85. 46.
    Burgi A, Brodine S, Wegner S et al (2005) Incidence and risk factors for the occurrence of non-AIDS-defi ning cancers among human immunodefi ciency virus-infected individuals. Cancer 104:1505–1511PubMedCrossRefGoogle Scholar
  86. 47.
    Oram Y, Orengo I, Griego RD et al (1995) Histologic patterns of basal cell carcinoma based upon patient imunosta-tus. Dermatol Surg 21:611–614PubMedCrossRefGoogle Scholar
  87. 48.
    Flegg PJ (1990) Potential risks of ultraviolet radiation in HIV infection. In J STD AIDS 1:46–48Google Scholar
  88. 49.
    Lobo DV, Chu P, Grekin RC, Berger TG (1992) Nonmelanoma skin cancers and infection with the human immunodefi -ciency virus. Arch Dermatol 128:623–627PubMedCrossRefGoogle Scholar
  89. 50.
    Wilkens K, Turner R, Dolev JC et al (2006) Cutaneous malignancy and human immunodefi ciency virus disease. J Am Acad Dermatol 54:189–206CrossRefGoogle Scholar
  90. 51.
    Nguyen P, Vin-Christian K, Ming ME, Berger T (2002) Aggressive squamous cell carcinomas in persons infected with the human immunodefi ciency virus. Arch Dermatol 138:758–763PubMedCrossRefGoogle Scholar
  91. 52.
    An KP, Ratner D (2001) Merkel cell carcinoma in the setting of HIV infection. J Am Acad Dermatol 45:309–312PubMedCrossRefGoogle Scholar
  92. 53.
    Calza L, Beltrami C, Manfredi R et al (2002) Merkel cell carcinoma in a human immunodefi ciency virus-infected patient. Br J Dermatol 146:895–898PubMedCrossRefGoogle Scholar
  93. 54.
    Colebunders R, Bottieau E, Van den Brande J et al (2004) Merkel cell carcinoma and multiple basal cell carcinoma in an African albino woman with HIV infection. HIV Medicine 5:452–453PubMedCrossRefGoogle Scholar
  94. 55.
    Engels EA, Frisch M, Goerdert JJ et al (2002) Merkel cell carcinoma and HIV infection. Lancet 359:497–498PubMedCrossRefGoogle Scholar
  95. 56.
    Solomon RK, Lundeen SJ, Hamlar DD, Pambuccian SE (2001) Fine needle aspiration diagnosis of unusual cutaneous neoplasms of the scalp in HIV-infected patients. Diagn Cytopathol 24:186–192PubMedCrossRefGoogle Scholar
  96. 57.
    Pantanowitz L, Schlecht HP, Dezube BJ (2006) The growing problem of non-AIDS-defi ning malignancies in HIV. Curr Opin Oncol 18:469–478PubMedCrossRefGoogle Scholar
  97. 58.
    Calista D (2001) Five cases of melanoma in HIV positive patients. Eur J Dermatol 11:446–944PubMedGoogle Scholar
  98. 59.
    Rodrigues LK, Klencke BJ, Vin-Christian K et al (2002) Altered clinical course of malignant melanoma in HIVpositive patients. Arch Dermatol 138:765–770PubMedCrossRefGoogle Scholar
  99. 1.
    Munoz N, Bosch FX, de Sanjose S et al (2003) International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: epidemiologic classification of human papil-lomavirus types associated with cervical cancer. N Engl J Med 348:518 –527PubMedCrossRefGoogle Scholar
  100. 2.
    Garland SM, Hernandez-Avila M, Weeher CM et al (2007) Quadrivalent vaccine against human papilloma virus to prevent anogenital disease. N Engl J Med 356:1928 –1943PubMedCrossRefGoogle Scholar
  101. 3.
    Markowitzh LE, Dunne EF, Saraiya M et al (2007) Quadrivalent human papilloma virus vaccine. MMWR 56:1 –24Google Scholar
  102. 4.
    Harper DM, Franco EL, Wheeler C et al (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364:1757 –1765PubMedCrossRefGoogle Scholar
  103. 5.
    Harper DM, Franco EL, Wheeler C et al (2006) Sustained efficacy up to 4,5 years of bivalent L1 virus-like particle vaccine against human papillomavirus types 16 an 18: follow-up from a randomised control trial. Lancet 367:1247 –1255PubMedCrossRefGoogle Scholar
  104. 6.
    Morath C, Mueller M, Goldschmidt H et al (2004) Malignancy in renal transplantation. J Am Soc Nephrol 15:1582 –1588PubMedCrossRefGoogle Scholar
  105. 7.
    Abbasakoor F, Boulos PB (2005) Anal intraepithelial neo-plasia. Br J Surg 92:277 –290PubMedCrossRefGoogle Scholar
  106. 8.
    Goldstone SE, Kawalek AZ, Huyett JW (2005) Infrared coagulator: a useful tool for treating anal squamous intraepi-thelial lesions. Dis Colon Rectum 48:1042 –1054PubMedCrossRefGoogle Scholar
  107. 9.
    Berry JM, Palefsky JM, Welton ML (2004) Anal cancer and its precursors in HIV-positive patients: perspectives and management. Surg Oncol Clin N Am 13:355 –373PubMedCrossRefGoogle Scholar
  108. 10.
    UKCCCR Anal Cancer Trial Working Party (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin. Lancet 348:1049 –1054CrossRefGoogle Scholar
  109. 11.
    Kreuter A, Reimann G, Esser S et al (2003) Screening and therapy of anal intraepithelial neoplasia (AIN) and anal carcinoma in patients with HIV-infection. Dtsch Med Wochenschr 128:1957 –1962PubMedCrossRefGoogle Scholar
  110. 12.
    Palefsky JM, Holly EA, Hogeboom CJ et al (1998) Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIVpositive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 17:314 –319PubMedCrossRefGoogle Scholar
  111. 13.
    Micali G, Nasca MR, Innocenzi D, Schwartz RA (2006) Penile cancer. J Am Acad Dermatol 54:369 –391PubMedCrossRefGoogle Scholar
  112. 14.
    Van der Avoort IA, Shirango H, Hoevenaars BM et al (2006) Vulvar squamous cell carcinoma is a multifactorial disese following two separate and independent pathways. Int J Gynecol Pathol 25:22 –92CrossRefGoogle Scholar
  113. 15.
    Pecorelli S (1998) FIGO annual report on the result of treatment in gynaecological cancer. J Epidemiol Biostat 3:1 –168Google Scholar
  114. 16.
    Krathen RA, Donelly HB (2007) Mohs micrographic surgery for squamous cell carcinoma arising within lichen scle-rosus. Dermatol Surg 33:990 –993PubMedCrossRefGoogle Scholar
  115. 17.
    Rasponellinin MR, Asirelli G, Taddei GL (2007) The role of angiogenesis and COX-2 expression in the evolution of vul-var lichen sclerosus to squamous cell carcinoma of the vulva. Gynecol Oncol 106:567 –571CrossRefGoogle Scholar
  116. 18.
    Fischer G, Bradford J (2007) Topical immunosuppressants, genital lichen sclerosus and the risk of squamous cell carcinoma: a case report. J Reprod Med 52:329 –331PubMedGoogle Scholar
  117. 19.
    Lewis FM, Neill SM (2007) Safety of calcineurin inhibitors in the management of lichen sclerosis. Br J Dermatol 156:1389 –1390PubMedCrossRefGoogle Scholar
  118. 20.
    El Shabrawi-Caelen L, Soyer HP, Schaeppi H et al (2004) Genital lentigines and melanocytic nevi with superimposed lichen sclerosus: a diagnostic challenge. J Am Acad Dermatol 50:690 –694CrossRefGoogle Scholar
  119. 21.
    Patrick RJ, Fenske NA, Messina JL (2007) Primary mucosal melanoma. J Am Acad Dermatol 56:828 –834PubMedCrossRefGoogle Scholar
  120. 22.
    Rohwedder A, Slominsi A, Wolff M et al (2007) Epider-modysplasia verruciformis and cutaneous human papilloma-virus DNA, but not genital human papillomavirus DNAs, are frequently detected in vulvar and vaginal melanoma. Am J Dermatopathol 29:13 –17PubMedCrossRefGoogle Scholar
  121. 23.
    Dhar KK, Das N, Brinkman DA et al (2007) Utility of sentinel node biopsy in vulvar and vaginal melanoma: report of two cases and review of the literature. Int J Gynecol Cancer 17:720 –723PubMedCrossRefGoogle Scholar
  122. 24.
    Jahnke A, Makovitzky J, Vriese V (2005) Primary melanoma of the female genital system: a report of 10 cases and review of the literature. Anticancer Res 25:1567 –1574PubMedGoogle Scholar
  123. 25.
    Sugiyama VE, Chan JK, Shin JY et al (2007) Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol 110:296 –301PubMedCrossRefGoogle Scholar
  124. 26.
    Manavi K, Kemmett D (2005) A case of penile superficial basal cell carcinoma involving the inner surface of foreskin. Int J STD AIDS 16:766 –767PubMedCrossRefGoogle Scholar
  125. 27.
    Pisani C, Poggiali S, De Padova L et al (2006) Basal cell carcinoma of the vulva. J Eur Acad Dermatol Venereol 20:446 –448PubMedCrossRefGoogle Scholar
  126. 28.
    Wang SO, Goldberg LH (2007) Multiple polypoid basal cell carcinomas on the perineum of a patient with basal cell nevus syndrome. J Am Acad Dermatol 57(Suppl 2):36 –37CrossRefGoogle Scholar
  127. 29.
    Siesling S, Elferink MA, van Dijck JA et al (2007) Epidemiology and treatment of extramammary Paget disease in the Nehterlands. Eur J Surg Oncol 33:951 –955PubMedCrossRefGoogle Scholar
  128. 30.
    Yang WJ, Kim DS, Im YJ et al (2005) Extramammary Paget 's disease of penis and scrotum. Urology 65:972PubMedCrossRefGoogle Scholar
  129. 31.
    Virich G, Gudi V, Canal A (2008) Extramammary Paget 's disease-occupational exposure to used engine oil and a new skin grafting technique. J Plast Reconstr Aesthet Surg 61:1528 –1529PubMedCrossRefGoogle Scholar
  130. 32.
    Tsujino Y, Kusatake K, Kneko S et al (2007) Fusion of singlephoton emission computed tomography and computed tomography images of sentinel lymph nodes in extramam-mary Paget 's disease of the scrotum. J Dermatol 34:712 –715PubMedCrossRefGoogle Scholar
  131. 33.
    Vereecken P, Awada A, Ghanem G et al (2007) A therapeutic approach to perianal extramammary Paget 's disease: topical imiquimod can be useful to prevent of defer surgery. Med Sci Monit 13:CS75 –7PubMedGoogle Scholar
  132. 34.
    Raspagliesi F, Fontanelli R, Rossi G et al (2006) Photody-namic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget 's disease of the vulva: a pilot study. Gynecol Oncol 103:581 –586PubMedCrossRefGoogle Scholar
  133. 35.
    Ye JN, Rhew DC, Yip F, Edelstein L (2006) Extramammary Paget 's diseae resistant to surgery and imiquimod monother-apy but responsive to imiquimod combination topical chemotherapy with 5-fluorouracil and retinoic aid: a case report. Cutis 77:245 –250PubMedGoogle Scholar
  134. 36.
    Zhu Y, Ye DW, Chen ZW et al (2007) Frozen section-guided wide local excision in the treatment of penoscrotal extra-mammary Paget 's disease. BJU Int 100:1282 –1287PubMedCrossRefGoogle Scholar
  135. 37.
    Oguchi S, Kaneko M, Uhara H, Saida T (2002) Docetaxil induced durable response in advanced extramammary Paget 's disease: a case report. J Dermatol 29:33 –37PubMedGoogle Scholar
  136. 38.
    Mochitomi Y, Sakamoto R, Gushi A et al (2005) Extramam-mary Paget 's disease/carcinoma successfully treated with a combination chemotherapy: report of two cases. J Dermatol 32:632 –637PubMedGoogle Scholar
  137. 39.
    Klimis T, Margaritopoulou A, Panopulos J, Kokotas N (2007) Primary classic penile Kaposi 's sarcoma in an elderly HIV-negative patient: report of a case and review of the literature. J BUON 12:117 –119PubMedGoogle Scholar
  138. 40.
    Micali G, Nasca MR, De Pasquale R, Innocenzi D (2003) Primary classic Kaposi 's sarcoma of the penis: report of a case and review. J Eur Acad Dermatol Venereol 17:320 –323PubMedCrossRefGoogle Scholar
  139. 41.
    Morelli L, Pusiol T, Piscioli F et al (2003) Herpesvirus 8-associated penile Kaposi 's sarcoma in an HIV-negative patient: first report of a solitary lesion. Am J Dermatopathol 25:28 –31PubMedCrossRefGoogle Scholar
  140. 42.
    Katongole-Mbidde E, Banura C, Nakakeeto M (1989) Diagnostic implicatons of genital Kaposi 's sarcoma. East Afr Med J 66:499 –502PubMedGoogle Scholar
  141. 43.
    Macasaet MA, Duerr A, Thelmo W et al (1995) Kaposi sarcoma presenting as a vulvar mass. Obstet Gynecol 86:695 –697PubMedCrossRefGoogle Scholar
  142. 44.
    Le Bourgeois JP, Frikha H, Pedbois P et al (1994) Radiotherapy in the management of epidemic Kaposi 's sarcoma of the oral cavity, the eyelid and the genitals. Radiother Oncol 30:263 –266PubMedCrossRefGoogle Scholar
  143. 45.
    Vapnek JM, Quivey JM, Carrol PR (1991) Acquired immu-nodeficiency syndrome-related Kaposi 's sarcoma of the male genitalia: management with radiation therapy. J Urol 146:333 –336PubMedGoogle Scholar
  144. 46.
    Swierzewski SJ III, Wan J, Boffini A, Faerber GJ (1993) The management of meatal obstruction due to Kaposi 's sarcoma of the glans penis. J Urol 150:193 –195PubMedGoogle Scholar
  145. 47.
    Nucci MR, Fletcher CD (2000) Vulvovaginal soft tissue tumours: update and review. Histopathology 36:97 –108PubMedCrossRefGoogle Scholar
  146. 48.
    Tsuji T, Yoshinaga M, Inomoto Y et al (2007) Aggressive angiomyxoma of the vulva with a sole t(5:8)(p15;q22) chromosome change. Int J Gynecol Pathol 26:494 –496PubMedCrossRefGoogle Scholar
  147. 49.
    Omori M, Toyoda H, Hirai T et al (2006) Angiomyofibro-blastoma of the vulva: a large pedunculated mass formation. Acta Med Okayama 60:237 –242PubMedGoogle Scholar
  148. 50.
    Nadal SR, Calore EE, Manzione CR et al (2005) Hypertrophic herpes simplex simulating anal neoplasia in AIDS patients: report of five cases. Dis Colon Rectum 48:2289 –2293PubMedCrossRefGoogle Scholar
  149. 51.
    Garman M, Metry D (2006) Vulvar synringomas in a 9-year-old child with review of the literature. Pediatr Dermatol 23:369 –372PubMedCrossRefGoogle Scholar
  150. 52.
    Kontogianni-Katsaros K, Kairi-Vassilatoy E, Grapsa D et al (2006) Angiokeratoma of the vulva: a rare benign vascular tumor mimicking malignancy –case report. Eur J Gynaecol Oncol 27:632 –633PubMedGoogle Scholar
  151. 53.
    Gupta R, Singh S, Nigam S, Khurana N (2006) Benign vascular tumors of female genital tract. Int J Gynecol Cancer 16:1195 –1200PubMedCrossRefGoogle Scholar
  152. 54.
    Kondi-Pafiti A, Kair-Vassilatou E, Spanidou-Carvouni H et al (2003) Vascular tumors o the female genital tract: a clinicopathological study of nine cases. Eur J Gynaecol Oncol 24:48 –50PubMedGoogle Scholar
  153. 55.
    Micheletti AM, Silva AC, Nascimento AG et al (2005) Cellular angiofibroma of the vulva: case report with clinico-pathological and immunohistochemistry study. Sao Paulo Med J 123:250 –252PubMedCrossRefGoogle Scholar
  154. 56.
    Misago N, Narisawa Y (2004) Polypoid basal cell carcinoma on the perianal region: a case report and review of the literature. J Dermatol 31:51 –55PubMedGoogle Scholar
  155. 57.
    Wieland U, Brockmeyer NH, Weissenborn SJ et al (2006) Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men. Arch Dermatol 142:1438 –1444PubMedCrossRefGoogle Scholar
  156. 1.
    Silverberg NB (2001) Update on malignant melanoma in children. Cutis 67:393–396PubMedGoogle Scholar
  157. 2.
    Strouse JJ, Fears TR, Tucker MA et al (2005) Pediatric melanoma: risk factor and survival analysis of the Surveillance, Epidemiology and End Results Database. J Clin Oncol 23:4735–4741PubMedCrossRefGoogle Scholar
  158. 3.
    Tate PS, Ronan SG, Feucht KA et al (1993) Melanoma in childhood and adolescence: clinical and pathological features of 48 cases. J Pediatr Surg 28:217–222PubMedCrossRefGoogle Scholar
  159. 4.
    Strojan P, Lamovec J (2000) Prepubertal malignant melanoma: report of three cases. Pediatr Hematol Oncol 17:163–169PubMedCrossRefGoogle Scholar
  160. 5.
    Holly EA, Kelly JW, Shpall SN et al (1987) Number of mel-anocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 17:459–468PubMedCrossRefGoogle Scholar
  161. 6.
    Skender-Kalnenas TM, English DR, Heenan PJ (1995) Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 33:1000–1007PubMedCrossRefGoogle Scholar
  162. 7.
    Bauer J, Garbe C (2003) Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data. Pigment Cell Res 16:297–306PubMedCrossRefGoogle Scholar
  163. 8.
    Whiteman DC, Whiteman CA, Green AC (2001) Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 12:69–82PubMedCrossRefGoogle Scholar
  164. 9.
    Oliveria SA, Saraiya M, Geller AC et al (2006) Sun exposure and risk of melanoma. Arch Dis Child 91:131–138PubMedCrossRefGoogle Scholar
  165. 10.
    Huynh PM, Grant-Kels JM, Grin CM (2005) Childhood melanoma: update and treatment. Int J Dermatol 44:715–723PubMedCrossRefGoogle Scholar
  166. 11.
    Schmid-Wendtner MH, Berking C, Baumert J et al (2002) Cutaneous melanoma in childhood and adolescence: an analysis of 36 patients. J Am Acad Dermatol 46:874–879PubMedCrossRefGoogle Scholar
  167. 12.
    Soares de Sá BC, Rezze GG, Scramim AP et al (2004) Cutaneous melanoma in childhood and adolescence: retrospective study of 32 patients. Melanoma Research 14:487–492CrossRefGoogle Scholar
  168. 13.
    Davidoff AM, Cirrincione C, Seigler HF (1994) Malignant melanoma in children. Ann Surg Oncol 1:278–282PubMedCrossRefGoogle Scholar
  169. 14.
    Swerdlow AJ, English JS, Qiao Z (1995) The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol 32:595–599PubMedCrossRefGoogle Scholar
  170. 15.
    Marghoob AA, Dusza S, Oliveria S et al (2004) Number of satellite nevi as a correlate for neurocutaneous melanocyto-sis in patients with large congenital melanocytic nevi. Arch Dermatol 140:171–175PubMedCrossRefGoogle Scholar
  171. 16.
    Arons MS, Hurwitz S (1983) Congenital nevocellular nevus: a review of the treatment controversy and a report of 46 cases. Plast Reconstr Surg 72:355–365PubMedCrossRefGoogle Scholar
  172. 17.
    Spatz A, Ruiter D, Hardmeier T et al (1996) Melanoma in childhood: an EORTC-MCG multicenter study on the clin-ico-pathological aspects. Int J Cancer 68:317–324PubMedCrossRefGoogle Scholar
  173. 18.
    Novakovic B, Clark WH Jr, Fears TR et al (1995) Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families. J Am Acad Dermatol 33:631–636PubMedCrossRefGoogle Scholar
  174. 19.
    Watt AJ, Kotsis SV, Chung KC (2004) Risk of melanoma arising in large congenital melanocytic nevi: a systematic review. Plast Reconstr Surg 113:1968–1974PubMedCrossRefGoogle Scholar
  175. 20.
    Bütter A, Hui T, Chapdelaine J et al (2005) Melanoma in children and the use of sentinel lymph node biopsy. J Pediatr Surg 40:797–800PubMedCrossRefGoogle Scholar
  176. 21.
    Schäfer-Hesterberg G, Schoengen A, Sterry W et al (2007) The use of ultrasound to early identify, diagnose and localize metastases in melanoma patients. Expert Rev Anticancer Ther 7(12):1707–1716PubMedCrossRefGoogle Scholar
  177. 22.
    Navid F, Furman WL, Fleming M et al (2005) The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma. Cancer 103:780–787PubMedCrossRefGoogle Scholar
  178. 23.
    Spitz S (1948) Melanomas of childhood. Am J Pathol 24:591–609PubMedGoogle Scholar
  179. 24.
    Barnhill RL, Barnhill MA, Berwick M et al (1991) The his-tologic spectrum of pigmented spindle cell nevus: a review of 120 cases with emphasis on atypical variants. Hum Pathol 22:52–58PubMedCrossRefGoogle Scholar
  180. 25.
    Massi G (2007) Melanocytic nevi simulant of melanoma with medicolegal relevance. Virchows Arch 451:623–647PubMedCrossRefGoogle Scholar
  181. 26.
    Ferrara G, Argenziano G, Soyer HP et al (2005) The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol 141:1381–1387PubMedCrossRefGoogle Scholar
  182. 27.
    Spatz A, Calonje E, Handfield-Jones S et al (1999) Spitz tumors in children: a grading system for risk stratification. Arch Dermatol 135:282–285PubMedCrossRefGoogle Scholar
  183. 28.
    King MS, Porchia SJ, Hiatt KM (2007) Differentiating spit-zoid melanomas from Spitz nevi through CD99 expression. J Cutan Pathol 34:576–580PubMedCrossRefGoogle Scholar
  184. 29.
    Kapur P, Selim MA, Roy LC et al (2005) Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohis-tochemical analysis. Mod Pathol 18:197–204PubMedCrossRefGoogle Scholar
  185. 30.
    Barnhill RL (2006) The Spitzoid lesion: rethinking Spitz tumors, atypical variants, ‘Spitzoid melanoma’ and risk assessment. Mod Pathol 19 Suppl 2:S21–S33PubMedCrossRefGoogle Scholar
  186. 31.
    Zangari A, Bernardini ML, Tallarico R et al (2007) Indications for the excision of nevi and melanoma diagnosed in a pediatric surgical unit. J Pediatr Surg 42:1412–1416PubMedCrossRefGoogle Scholar
  187. 32.
    Casso EM, Grin-Jorgensen CM, Grant-Kels JM (1992) Spitz nevi. J Am Acad Dermatol 27:901–913PubMedCrossRefGoogle Scholar
  188. 33.
    Shapiro PE (1993) Spitz nevi. J Am Acad Dermatol 29:667–668PubMedCrossRefGoogle Scholar
  189. 34.
    LeBoit PE (2002) “Safe” Spitz and its alternatives. Pediatr Dermatol 19:163–165PubMedCrossRefGoogle Scholar
  190. 35.
    Setterfield J, Sciot R, Debiec-Rychter M et al (2002) Primary cutaneous epidermotropic alveolar rhabdomyosarcoma with t(2;13) in an elderly women. Am J Surg Pathol 26:938–944PubMedCrossRefGoogle Scholar
  191. 36.
    Lobe TE, Wiener ES, Hays DM et al (1994) Neonatal rhab-domyosarcoma: the IRS experience. J Pediatr Surg 29:1167–1170PubMedCrossRefGoogle Scholar
  192. 37.
    Toro JR, Travis LB, Wu HJ et al (2006) Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: an analysis of 26,758 cases. Int J Cancer 119:2922–2930PubMedCrossRefGoogle Scholar
  193. 38.
    Brecher AR, Reyes-Mugica M, Kamino H et al (2003) Congenital primary cutaneous rhabdomyosarcoma in a neo-nate. Pediatr Dermatol 20:335–338PubMedCrossRefGoogle Scholar
  194. 39.
    Taylor RW (1890) Sarcomatous tumors resembling in some respects keloids. Arch Dermatol 8:384–387Google Scholar
  195. 40.
    Hoffmann E (1925) Über das knollentreibende Fibrosarkom der Haut (Dermatofibrosarcoma protuberans). Dermat Zeitschr 43:1–28CrossRefGoogle Scholar
  196. 41.
    Craver RD, Correa H, Kao YS et al (1995) Aggressive giant cell fibroblastoma with a balanced 17;22 translocation. Cancer Genet Cytogenet 80:20–22PubMedCrossRefGoogle Scholar
  197. 42.
    Minoletti F, Miozzo M, Pedeutour F et al (1995) Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protu-berans. Genes Chromosomes Cancer 13:62–65PubMedCrossRefGoogle Scholar
  198. 43.
    Pedeutour F, Simon MP, Minoletti F et al (1996) Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. Cytogenet Cell Genet 72:171–174PubMedCrossRefGoogle Scholar
  199. 44.
    Jha P, Moosavi C, Fanburg-Smith JC (2007) Giant cell fibro-blastoma: an update and addition of 86 new cases from the armed forces institute of pathology, in honor of Dr. Franz Enzinger. Ann Diagn Pathol 11:81–88PubMedCrossRefGoogle Scholar
  200. 45.
    Dupree WB, Langloss JM, Weiss SW (1985) Pigmented der-matofibrosarcoma protuberans (Bednar tumor). A pathologic, ultrastructural, and immunohistochemical study. Am J Surg Pathol 9:630–639PubMedCrossRefGoogle Scholar
  201. 46.
    McPeak CJ,Cruz T,Nicastri AD (1967) Dermatofibrosarcoma protuberans: an analysis of 86 cases — five with metastasis Ann Surg 166:803–816PubMedCrossRefGoogle Scholar
  202. 47.
    von Stebut E, Bräuninger W (2007) Congenital dermatofib-rosarcoma protuberans: 30 years of follow-up. JDDG 5:223–225CrossRefGoogle Scholar
  203. 48.
    NG A, Nishikawa H, Lander A et al (2005) Chemosensitivity in pediatric dermatofibrosarcoma protuberans. J Pediatr Hematol Oncol 27:100–102PubMedCrossRefGoogle Scholar
  204. 49.
    Rubin BP, Schuetze SM, Eary JF et al (2002) Molecular targeting of platelet-derived growth factor B by imatinib mesy-late in a patient with metastatic dermatofibrosarcoma protuberans. J Clin Oncol 20:3586–3591PubMedCrossRefGoogle Scholar
  205. 50.
    Price VE, Fletcher JA, Zielenska M et al (2004) Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuber-ans. Pediatr Blood Cancer 44:511–515CrossRefGoogle Scholar
  206. 1.
    Bazex A, Griffiths A (1980) Acrokeratosis paraneoplastica. A new cutaneous marker of malignancy. Br J Dermatol 102:304Google Scholar
  207. 2.
    Bolognia JL, Brewer YP, Cooper DL (1991) Bazex 's syndrome. Analytic review. Medicine 70:269 –280Google Scholar
  208. 3.
    Richard M, Giroux JM (1987) Acrokeratosis paraneoplastic (Bazex syndrome). J Am Acad Dermatol 16:178 –183PubMedCrossRefGoogle Scholar
  209. 1.
    Lemont H, Haas R (1994) Subungual pigmented Bowen 's disease in a nineteen-year-old black female. J Am Podiatr Med Assoc 84:39 –40PubMedGoogle Scholar
  210. 2.
    Saijo S, Kato T, Tagami H (1990) Pigmented nail streak associated with Bowen 's disease of the nail matrix. Dermatologica 181:156 –158PubMedCrossRefGoogle Scholar
  211. 3.
    Henry M, Renaut JJ, Baran R et al (2003) Bande pigmentée unguéale acquise, révélatrice d'un carcinome épidermoïde du lit de l'ongle. Nouv Dermatol 22(Suppl 2):19 –20Google Scholar
  212. 4.
    Baran R, Simon C (1988) Longitudinal melanonychia: a symptom of Bowen 's disease. J Am Acad Dermatol 18: 1359 –1360PubMedCrossRefGoogle Scholar
  213. 5.
    Baran R, Eichmann A (1993) Longitudinal melanonychia associated with Bowen disease. Dermatology 186:159 –160PubMedCrossRefGoogle Scholar
  214. 6.
    Sass U, André J, Stene JJ et al (1998) Longitudinal mel-anonychia revealing an intraepidermal carcinoma of the nail apparatus: detection of integrated HPV-16 DNA. J Am Acad Dermatol 39:490 –493PubMedCrossRefGoogle Scholar
  215. 7.
    Haneke E (1991) Epidermoid carcinoma (Bowen 's disease) of the simulating acquired ungual fibrokeratoma. Skin Cancer 6:217 –221Google Scholar
  216. 8.
    Baran R, Perrin C (1987) Pseudo-fibrokeratoma of the nail apparatus: a new clue for Bowen disease. Arch Dermatol 74:449 –450Google Scholar
  217. 9.
    Dominguez-Cherit J, Garcia C, Vega-Memije ME, Arenas R (2003) Pseudo-fibrokeratoma: an unusual presentation of subungual squamous cell carcinoma in a young girl. Dermatol Surg 29:788 –789CrossRefGoogle Scholar
  218. 10.
    Sau P, McMarlin SL, Sperling LC et al (1994) Bowen 's disease of the nail bed and periungual area. A clinicopathologic analysis of seven cases. Arch Dermatol 130:204 –209PubMedCrossRefGoogle Scholar
  219. 11.
    Saxena A, Kasper DA, Campanelli CD et al (2006) Pigmented Bowen 's disease clinically mimicking melanoma of the nail. Dermatol Surg 32:152 –155CrossRefGoogle Scholar
  220. 12.
    Baran R, Perrin C (2000) Longitudinal erythronychia with distal subungual keratosis: onychopapilloma of the nail bed and Bowen 's disease. Br J Dermatol 143:132 –135PubMedCrossRefGoogle Scholar
  221. 13.
    Dalle S, Depape L, Phan A et al (2007) Squamous cell carcinoma of the nail apparatus: clinicopathological study of 35 cases. Br J Dermatol 156:871 –874PubMedCrossRefGoogle Scholar
  222. 14.
    Reuter G, Keller F, Samama et al (2005) Maladie de Bowen à type d'Erythronychie longitudinale. Aspect dermoscopique et étude virologique. Ann Dermatol Venereol 132:596CrossRefGoogle Scholar
  223. 15.
    Baran R, Gormley D (1987) Polydactylous Bowen 's disease of the nail. J Am Acad Dermatol 17:201 –204PubMedCrossRefGoogle Scholar
  224. 16.
    Goodman G, Mason G, O'Brien T (1995) Polydactylous Bowen 's disease of the nail bed. Aust J Dermatol 36: 164 –165CrossRefGoogle Scholar
  225. 17.
    Koch A, Schönlebe J, Haroske G et al (2003) Polydactylous Bowen 's disease. JEADV 17:213 –215PubMedGoogle Scholar
  226. 18.
    Baran R, Tosti A, De Berker D (2003) Periungual keratoacan-thoma preceded by a wart and followed by a verrucous carcinoma at the same site. Acta Derm Venereol 83:232 –233PubMedCrossRefGoogle Scholar
  227. 19.
    High WA, Tyring SK, Taylor RS (2003) Rapidly enlarging growth of the proximal nail fold. Dermatol Surg 29:984 –986PubMedCrossRefGoogle Scholar
  228. 20.
    Baran R, Perrin C (2002) Bowen 's disease clinically simulating an onychomatricoma. J Am Acad Dermatol 47:947 –949PubMedCrossRefGoogle Scholar
  229. 21.
    Chang SE, Choi JH, Sung KJ et al (1999) Metastatic squamous cell carcinoma of the nail bed: a presenting sign of lung cancer (letter). Br J Dermatol 141(5):939 –940CrossRefGoogle Scholar
  230. 22.
    Vanhooteghem O, Dumont M, André J et al (1999) Métastases sous-unguéales bilatérales de carcinome spino-cellulaire pulmonaire: un piège diagnostique! Rev Med Liege. 54(8):653 –654Google Scholar
  231. 23.
    Forslund O, Nordin P, Andersson K et al (1997) DANN analysis indicates patient-specific human papillomavirus type 16 strains in Bowen 's disease of fingers and in archival samples from genital dysplasia. Br J Dermatol 136: 678 –682PubMedCrossRefGoogle Scholar
  232. 24.
    Tosti A, Morelli K, Fanti PA et al (1993) Carcinoma cunicu-latum of the nail apparatus: report of three cases. Dermatol 186:217 –221CrossRefGoogle Scholar
  233. 25.
    Van Geertruyden JP, Olemans C, Laporte M et al (1998) Verrucous carcinoma of the nail bed. Foot Ankle Int 19:327 –328PubMedGoogle Scholar
  234. 26.
    Spencer JM (2002) Malignant tumors of the nail unit. Dermatol Ther 15:126 –130CrossRefGoogle Scholar
  235. 27.
    Laffitte E, Saurat JH (2003) Maladie de Bowen unguéale récidivante: traitement par imiquimod topique (Aldara). Ann Dermatol Venereol 130:211 –213PubMedGoogle Scholar
  236. 28.
    Tan B, Sinclair R, Foley P (2004) Photodynamic therapy for subungual Bowen 's disease. Australas J Dermatol 45: 172 –174PubMedCrossRefGoogle Scholar
  237. 29.
    Wong TW, Sheu HM, Lee YY et al (2001) Photodynamic therapy for Bowen 's disease (squamous cell carcinoma in situ) of the digit. Dermatol Surg 27:452 –456PubMedCrossRefGoogle Scholar
  238. 30.
    Sheen YS, Sheen MC, Sheu HM (2003) Squamous cell carcinoma of the big toe successfully treated by intra-arterial infusion with methotrexate. Dermatol Surg 29:982 –983PubMedCrossRefGoogle Scholar
  239. 1.
    Albert LI, Zack FG, Werthamer S (1972) Subungual basal cell epithelioma. Arch Dermatol 106:599Google Scholar
  240. 2.
    Mikhail GR (1985) Subungual basal cell carcinoma. J Dermatol Surg Oncol 11:1222–1223PubMedGoogle Scholar
  241. 3.
    Brazie RA, Patel A, Nouri K (2006) Basal cell carcinoma of the nail unit treated with Mohs micrographic surgery: superfi-cial multicentric BCC with jagged borders — an histopathologi-cal hallmark for nail unit BCC. J Drugs Dermatol 5:660–663Google Scholar
  242. 4.
    Martinelli PT, Cohen PR, Schulze KE et al (2006) Periungual basal cell carcinoma: case report and literature review. Dermatol Surg 32:320–323PubMedCrossRefGoogle Scholar
  243. 5.
    Rudolph RI (1987) Subungual basal cell carcinoma presenting as longitudinal melanonychia. J Am Acad Dermatol 16:229–233PubMedCrossRefGoogle Scholar
  244. 6.
    Okuyama R, Watanabe H, Alba S et al (2006) Subungual basal cell carcinoma in an elderly Japanese woman. Acta Derm Venereol 86:261PubMedCrossRefGoogle Scholar
  245. 7.
    Hoffman S (1973) Basal cell carcinoma of the nail bed. Arch Dermatol 108:828PubMedCrossRefGoogle Scholar
  246. 1.
    Baran R, Tosti A (1994) Metastatic bronchogenic carcinoma to the terminal phalanx of the toe. Report of 2 cases and review of the literature. J Am Acad Dermatol 31:259–263PubMedCrossRefGoogle Scholar
  247. 2.
    Cohen P (2001) Metastatic tumors to the nail unit: subungual metastases. Dermatol Surg 27:280–293PubMedGoogle Scholar
  248. 3.
    Gallagher B, Yousef G, Bishop L (2006) Subungual metastasis from a rectal primary: case report and review of the literature. Dermatol Surg 32:592–595PubMedCrossRefGoogle Scholar
  249. 4.
    Retsas S, Samman PD (1983) Pigment streaks in the nail plate due to secondary malignant melanoma. Br J Dermatol 108:367–370PubMedCrossRefGoogle Scholar
  250. 5.
    Spencer JM (2002) Malignant tumors of the nail unit. Dermatol Ther 15:126–130CrossRefGoogle Scholar
  251. 1.
    Metzger S, Ellwanger U, Stroebel W et al (1998) Extent and consequences of physician delay in the diagnosis of acral melanoma. Melanoma Res 8:181–186PubMedCrossRefGoogle Scholar
  252. 2.
    Kopf AW, Bart RS (1977) Malignant melanoma. J Surg Oncol 3:49–53Google Scholar
  253. 3.
    Levit EK, Kagen MH, Scher RK (2000) The ABC rule for clinical detection of subungual melanoma. J Am Acad Dermatol 42:269–274PubMedCrossRefGoogle Scholar
  254. 4.
    Kato T, Suetake T, Sugiyama Y et al (1996) Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol 134:383–387PubMedCrossRefGoogle Scholar
  255. 5.
    Thai KE, Young R, Sinclair RD (2001) Nail apparatus melanoma. Australas J Dermatol 42(2):71–81PubMedCrossRefGoogle Scholar
  256. 6.
    Clark WH, Bernardino EA, Reed RJ et al (1979) Acral len-tiginous melanoma. In: Clark WH, Geodman LI, Mastrangers (eds) Human malignant melanoma. Grune & Stratton, New York, pp 109–124Google Scholar
  257. 7.
    Milton GH, Show HM, Mc Carthy WH (1985) Subungual malignant melanoma. A disease entity separate from other forms of cutaneous melanoma. Australas J Dermatol 26:61–64PubMedCrossRefGoogle Scholar
  258. 8.
    Miura S, Jimbow K (1985) Clinical characteristics of subun-gual melanoma in Japan. Case report and questionnaire survey of 108 cases. J Dermatol 12:393–402PubMedGoogle Scholar
  259. 9.
    Baran R, Kechijian P (1989) Longitudinal melanonychia. Diagnosis and management. J Am Acad Dermatol 21:1165–1175PubMedCrossRefGoogle Scholar
  260. 10.
    Haneke E, Baran R (2001) Longitudinal melanonychia. Dermatol Surg 27(6):580–584PubMedCrossRefGoogle Scholar
  261. 11.
    Nogaret JM, André J, Parent D et al (1986) Le mélanome des extrémités, diagnostic méconnu et traitement délicat. Revue des 20 observations. Acta Chir Belg 86:238–244PubMedGoogle Scholar
  262. 12.
    Retsas S, Samman PD (1983) Pigment streaks in the nail plate due to secondary malignant melanoma. Br J Dermatol 108:367–370PubMedCrossRefGoogle Scholar
  263. 13.
    Ronger S, Touzet S, Ligeton C et al (2002) Dermoscopic examination of nail pigmentation. Arch Dermatol 138:1327–1333PubMedCrossRefGoogle Scholar
  264. 14.
    Kopf AW (1981) Hutchinson 's sign of subungual malignant melanoma. Am J Dermatopathol 3:201–202PubMedCrossRefGoogle Scholar
  265. 15.
    Baran R, Kechijian P (1996) Hutchinson 's sign: a reappraisal. J Am Acad Dermatol 34:87–90PubMedCrossRefGoogle Scholar
  266. 16.
    Kawabata Y, Ohara K, Hino H et al (2001) Two kinds of Hutchinson 's sign: benign and malignant. J Am Acad Dermatol 44(2):305–307PubMedCrossRefGoogle Scholar
  267. 17.
    André J, Lateur N (2006) Pigmented nail disorders. Dermatol Clin 24:329–340PubMedCrossRefGoogle Scholar
  268. 18.
    Banfield CC, Redburn JC, Dawber RPR (1998) The incidence and prognosis of nail apparatus melanoma. A retrospective study of 105 patients in four English regions. Br J Dermatol 139:276–279PubMedCrossRefGoogle Scholar
  269. 19.
    Achten G (1982) What 's new about normal and pathologic nail. Abstracts in XVI International Congress of Dermatology, Tokyo, 17–18Google Scholar
  270. 20.
    Perrin C, Baran R (1994) Longitudinal melanonychia caused byTrichophyton rubrum. J Am Acad Dermatol 31:311–316PubMedCrossRefGoogle Scholar
  271. 21.
    Jellinek NJ (2005) Primary malignant tumors of the nail unit. Adv Dermatol 21:33–64PubMedCrossRefGoogle Scholar
  272. 22.
    Banfield CC, Dawber RPR, Walker NP et al (1999) Mohs micrographic surgery for the treatment of in situ nail apparatus melanoma: a case report. J Am Acad Dermatol 40:98–99PubMedCrossRefGoogle Scholar
  273. 1.
    Gloster HM and Neal K (2006) Skin Cancer in Skin of Color, J Am Acad Dermatol 55:761–764CrossRefGoogle Scholar
  274. 2.
    Halder RM, Bang KM (1988) Skin cancer in blacks in the United States. Dermatol Clin 6:397–405PubMedGoogle Scholar
  275. 3.
    Halder RM, Bridgeman-Shah S (1995) Skin cancer in African Americans. Cancer 75:667–673PubMedCrossRefGoogle Scholar
  276. 4.
    Mora RG, Perniciaro C (1981) Cancer of the skin in blacks: I. a review of 163 black patients with cutaneous squamous cell carcinoma. J Am Acad Dermatol 5:535–543PubMedCrossRefGoogle Scholar
  277. 5.
    Fleming ID, Barnawell JR, Burlison PE, Runkin JS (1975) Skin cancer in black patients. Cancer 35:600–605PubMedCrossRefGoogle Scholar
  278. 6.
    Crowley NJ, Dodge R, Vollmer RT, Seigler HF (1991) Malignant melanoma in African Americans: a trend towards improved survival. Arch Surg 126:1359–6135PubMedCrossRefGoogle Scholar
  279. 7.
    Mora RG, Burris R (1981) Cancer of the skin in African Americans: a review of 128 patients with basal cell carcinoma. Cancer 47:1436–1438PubMedCrossRefGoogle Scholar
  280. 8.
    Koh D, Wang H, Lee J, Chia KS, Lee HP, Goh CL (2003) Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry Data 1968e 1997. Br J Dermatol 148:1161–1166PubMedCrossRefGoogle Scholar
  281. 9.
    Budhraja SN, Pillai VC, Periyanayagam WJ, Kaushik SP, Bedi BM (1972) Malignant neoplasms of the skin in Pondicherry (a study of 102 cases). Indian J Cancer 9:284–295PubMedGoogle Scholar
  282. 10.
    Chakravorty RC, Dutta-Choudhuri R (1968) Malignant neoplasms of the skin in eastern India. Indian J Cancer 5:133–414PubMedGoogle Scholar
  283. 11.
    Paymaster JC, Talwalkar G V, Gangadharan D (1971) Carcinomas and malignant melanomas of the skin in western India. J Royal Coll Surg 16:166–173Google Scholar
  284. 12.
    Shahi UP, Fernandes P, Shukla NK, Chandler S, Eoin B, Rath GK (1989) Electron beam irradiation in treatment of skin carcinoma. Indian J Cancer 26:41–45PubMedGoogle Scholar
  285. 13.
    Dhir A, Orengo I, Bruce S, Kolbusz RV, Alford E, Goldberg L (1995) Basal cell carcinoma on the scalp of an Indian patient. Dermatol Surg 21:247–250PubMedGoogle Scholar
  286. 14.
    Scotto J, Fears TR, Fraumeni JF Jr (1981) Incidence of nonmelanoma skin cancer in the United States. US Government Printing Office, Washington, DC. National Cancer Institute, DHHS Report No. NIH 82–2433Google Scholar
  287. 15.
    Gloster HM, Brodland DG (1996) The epidemiology of skin cancer. Dermatol Surg 22:217–226PubMedCrossRefGoogle Scholar
  288. 16.
    Armstrong BK, Kricker A (1995) Skin cancer. Dermatol Clin 13:583–954PubMedGoogle Scholar
  289. 17.
    Hall HI, Miller DR, Rogers JD, Bevers B (1999) Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 40:35–42PubMedCrossRefGoogle Scholar
  290. 18.
    Ichihashi M, Naruse K, Harada S, Nagano T, Nakamura T, Suzuki T et al (1995) Trends in nonmelanoma skin cancer in Japan. Recent Results Cancer Res 139:263–723PubMedCrossRefGoogle Scholar
  291. 19.
    Naruse K, Ueda M, Nagano T, Suzuki T (1997) Prevalence of actinic keratoses in Japan. J Dermatol Sci 15:183–187PubMedCrossRefGoogle Scholar
  292. 20.
    Harris RB, Griffith K, Moon TE (2001) Trends in incidence of nonmelanoma skin cancers in southeastern Arizona, 1985–1996. J Am Acad Dermatol 45:528–536PubMedCrossRefGoogle Scholar
  293. 21.
    Weinstock MA (1993) Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Arch Dermatol 129:1286–1290PubMedCrossRefGoogle Scholar
  294. 22.
    Ries LA, Kosary CL, Hankey BF, Miller BA (eds) (1997) SEER cancer statistics review, 1973e1994 (NIH Publication no. 97–2789). National Cancer Institute, Bethesda (MD)Google Scholar
  295. 23.
    US Census Bureau Population Division (2000) Projections of the resident population by race, Hispanic origin, and nativity: middle series, 1999–2100. US Census Bureau, Washington, DCGoogle Scholar
  296. 24.
    Montagna W, Prota G, Kenney JA Jr (1993) Black skin structure and function. Academic Press, London, pp 55–60Google Scholar
  297. 25.
    Anderson KE (1979) Black and white human skin differences. J Am Acad Dermatol 1:276–282CrossRefGoogle Scholar
  298. 26.
    Montagna W (1991) The architecture of black and white skin. J Am Acad Dermatol 24:29–37CrossRefGoogle Scholar
  299. 27.
    Kollias N, Sayre RM, Zeise L, Chedekel MR (1991) Protection by melanin. J Photochem Photobiol 9:135–160CrossRefGoogle Scholar
  300. 28.
    Foster HM, Webb SJ (1988) Skin cancer in the North Solomons. Aust N Z J Surg. 58(5):397–401PubMedCrossRefGoogle Scholar
  301. 29.
    Madronich S, de Gruijl FR (1993) Skin cancer and UV radiation. Nature 366:23PubMedCrossRefGoogle Scholar
  302. 30.
    Armstrong BK, Kricker A (2001) The epidemiology of UV induced skin cancer. J Photochem Photobiol B 63:8–18PubMedCrossRefGoogle Scholar
  303. 31.
    Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DS (1996) Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol Symp Proc 1:136–142Google Scholar
  304. 32.
    Scotto J, Fears TR, Fraumeni JF (1983) Incidence of non-melanoma skin cancer in the United States. US Government Printing Office, Washington, DC, NIH Report No. 83–2433Google Scholar
  305. 33.
    Weinstock MA (1993) Epidemiology of melanoma. Cancer Treat Res 65:29–56PubMedCrossRefGoogle Scholar
  306. 34.
    Dennis LK, White E, Lee JA (1994) Recent cohort trends in malignant melanoma by anatomic site in the United States. Cancer Causes Control 5:440–448PubMedCrossRefGoogle Scholar
  307. 35.
    Chuang TY, Reizner GT, Elpern DJ, Stone JL, Farmer ER (1995) Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report. J Am Acad Dermatol 33:422–642PubMedCrossRefGoogle Scholar
  308. 36.
    Penello GA, Devesa S, Gail M (2000) Association of surface ultraviolet B radiation levels with melanoma and non-melanoma skin cancer in United States blacks. Cancer Epidemiol Biomarkers Prev 9:291–297Google Scholar
  309. 37.
    Penello GA, Devesa S, Gail M (1999) Using a mixed effects model to estimate geographic variation in cancer rates. Biometrics 55:774–781CrossRefGoogle Scholar
  310. 38.
    Scotto J, Fears TR, Kraemer KH, Fraumeni JF (1996) Nonmelanoma skin cancer. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention, 2nd edn. Oxford University Press, New York, pp 1313–1330Google Scholar
  311. 39.
    Shapiro MP, Keen P, Cohen L (1953) Skin cancer in the South African Bantu. Br J Cancer 7:45–57PubMedCrossRefGoogle Scholar
  312. 40.
    Oluwasanmi JO, Williams AO, Alli AF (1969) Superficial cancer in Nigeria. Br J Cancer 23:714–278PubMedCrossRefGoogle Scholar
  313. 41.
    Crockett DJ (1962) Colour, cancer, and keloids in the Sudan. Br J Plast Surg 15:408–146PubMedCrossRefGoogle Scholar
  314. 42.
    Singh B, Bhaya M, Shaha A, Har-El G, Lucente FE (1998) Presentation, course, and outcome of head and neck cancer in African Americans: a case control study. Laryngoscope 108:1159–1163PubMedCrossRefGoogle Scholar
  315. 43.
    Abreo F, Sanusi D (1991) Basal cell carcinoma in North American blacks: clinical and histopathologic study of 26 patients. J Am Acad Dermatol 25:1005–1101PubMedCrossRefGoogle Scholar
  316. 44.
    Altman A, Rosen T, Tschen JA, Hoffman T, Bruce S, Siegel DM et al (1987) Basal cell epithelioma in black patients. J Am Acad Dermatol 17:741–574PubMedCrossRefGoogle Scholar
  317. 45.
    Kikuchi A, Shimizu H, Nishikawa T (1996) Clinical and histopathological characteristics of basal cell carcinoma in Japanese patients. Arch Dermatol 132:320–324PubMedCrossRefGoogle Scholar
  318. 46.
    Hu S, Fangchao M, Collado-Mesa F, Kirsner RS (2004) UV radiation, latitude, and melanoma in US Hispanics and blacks. Arch Dermatol 140:819–824PubMedCrossRefGoogle Scholar
  319. 47.
    Yohn JJ, Lupins MB, Norris DA (1982) Cultured melano-cytes from African American and white donors have different sunlight and ultraviolet A radiation sensitivities. J Invest Dermatol 99:454–459CrossRefGoogle Scholar
  320. 48.
    Eide MJ, Weinstock MA (2005) Association of UV index, latitude, and melanoma incidence in non-white populations: US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001. Arch Dermatol 141:477–481PubMedCrossRefGoogle Scholar
  321. 49.
    Fitzpatrick TB (1989) Enigma of the pathogenesis of primary melanoma: changing incidence and mortality in Japan and the United States. J Invest Dermatol 92:234–236CrossRefGoogle Scholar
  322. 50.
    Amir H, Mbonde MP, Kitinya JN (1992) Cutaneous squamous cell carcinoma in Tanzania. Cent Afr J Med 38:439–443PubMedGoogle Scholar
  323. 51.
    Gray DT, Suman VJ, Su WP, Clay RP, Harmsen WS, Roenigk RK (1997) Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 133:735–740PubMedCrossRefGoogle Scholar
  324. 52.
    Hoy WE (1996) Nonmelanoma skin cancer in Albuquerque, New Mexico. Cancer 77:2489–2495PubMedCrossRefGoogle Scholar
  325. 53.
    Ishihara K, Saida T, Yamamato A (2001) Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol 6:109–116PubMedCrossRefGoogle Scholar
  326. 54.
    Suzuki T, Ueda M, Naruse K, Nagano T, Harada S, Imaizumi K et al (1997) Incidence of actinic keratosis of Japanese in Kasai City, Hyogo. J Dermatol Sci 16:74–78PubMedCrossRefGoogle Scholar
  327. 55.
    Nagano T, Ueda M, Suzuki T, Naruse K, Nakamura T, Taguchi M et al (1999) Skin cancer screening in Okinawa. Japan. J Dermatol Sci 19:161–165PubMedCrossRefGoogle Scholar
  328. 56.
    Washington CV, Grimes PE (2003) Incidence and prevention of skin cancer. Cosmetic Dermatol 16:46–48Google Scholar
  329. 57.
    McCall CO, Chen SC (2002) Squamous cell carcinoma of the legs in African Americans. J Am Acad Dermatol 47:524–529PubMedCrossRefGoogle Scholar
  330. 58.
    Mora RG, Perniciaro C, Lee B (1984) Cancer of the skin in blacks III: a review of nineteen black patients with Bowen 's disease. J Am Acad Dermatol 11:557–562PubMedCrossRefGoogle Scholar
  331. 59.
    Yakubu A, Maboguaje OA (1995) Squamous cell carcinoma of the skin in Africans. Trop Geogr Med 47:91–93PubMedGoogle Scholar
  332. 60.
    Rippentrop JM, Joslyn SA, Konety BR (2004) Squamous cell carcinoma of the penis: evaluation of data from Surveillance, Epidemiology, and End Results program. Cancer 101:1357–6133PubMedCrossRefGoogle Scholar
  333. 61.
    Schamroth JM, Weiss RM, Grieve TP (1987) Verrucous Bowen 's disease in an African American patient. S Afr Med J 71:527–852PubMedGoogle Scholar
  334. 62.
    Krishnan R, Lewis A, Orengo IF, Rosen T (2001) Pigmented Bowen 's disease (squamous cell carcinoma in-situ): a mimic of malignant melanoma. Dermatol Surg 27:673–674PubMedCrossRefGoogle Scholar
  335. 63.
    Papageorgiou PP, Koumarianou AA, Chu AC (1998) Pigmented Bowen 's disease. Br J Dermatol 138:515–518PubMedCrossRefGoogle Scholar
  336. 64.
    Rosen T, Tucker SB, Tschen J (1982) Bowen 's disease in African Americans. J Am Acad Dermatol 7:364–368PubMedCrossRefGoogle Scholar
  337. 65.
    Sherman RN, Lee CW, Flynn KJ (1993) Cutaneous squamous cell carcinoma in African American patients with chronic discoid lupus erythematous. Int J Dermatol 32:677–679PubMedCrossRefGoogle Scholar
  338. 66.
    Arrington JH III, Lockman DS (1979) Thermal keratoses and squamous cell carcinoma in situ associated with erythema ab igne. Arch Dermatol 115:1226–1228PubMedCrossRefGoogle Scholar
  339. 67.
    Schwartz RA, Stoll HL Jr (1999) In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith CA, Karz SI et al (eds) Fitzpatrick 's dermatology in general medicine, 5th edn. McGraw-Hill, NewYork, pp 841–842Google Scholar
  340. 68.
    Keith WD, Kelly P, Sumrall AJ (1980) Squamous cell carcinoma arising in lesions of discoid lupus erythematosus in black persons. Arch Dermatol A6:315–317CrossRefGoogle Scholar
  341. 69.
    Schoeman BJ (1996) Squamous cell carcinoma in neuropathic plantar ulcers in leprosy: another example of Marjolin 's ulcer. S Afr Med J 86:966–969PubMedGoogle Scholar
  342. 70.
    Rowe DE, Carroll RJ, Day CL (1992) Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol 26:976–990PubMedCrossRefGoogle Scholar
  343. 71.
    Mora RG (1986) Surgical and aesthetic consideration of cancer of the skin in the black American. Am J Dermatol Surg Oncol 12:24–31Google Scholar
  344. 72.
    Nadiminti U, Rakkhit T, Washington C (2004) Morpheaform basal cell carcinoma in African Americans. Dermatol Surg 30:1550–2155PubMedCrossRefGoogle Scholar
  345. 73.
    Lesher JL, D'Aubermont PCS, Brown VM (1988) Morpheaform basal cell carcinoma in a young black woman. J Dermatol Surg Oncol 14:200–203PubMedGoogle Scholar
  346. 74.
    Shreck R (1944) Cutaneous carcinoma IV: analysis of 20 cases in Negroes. Cancer Res 4:119–129Google Scholar
  347. 75.
    Munyao TM, Othieno-Abinya NA (1999) Cutaneous basal cell carcinoma in Kenya. East Afr Med J 76:97–100PubMedGoogle Scholar
  348. 76.
    Miller DL, Weinstock MA (1994) Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30:774–778PubMedCrossRefGoogle Scholar
  349. 77.
    Tada M, Miki Y (1984) Malignant skin tumors among dermatology patients in university hospitals of Japan: a statistical survey, 1971–1975. J Dermatol 11:313–321PubMedGoogle Scholar
  350. 78.
    Schreiber MM, Shapiro SI, Berry CZ, Dahlen RF, Friedman RP (1971) The incidence of skin cancer in southern Arizona (Tucson). Arch Dermatol 104:124–127PubMedCrossRefGoogle Scholar
  351. 79.
    Zhang B, Wang N, He W (1993) Clinicopathologic analysis of 60 cases of basal cell carcinoma. Chin Med Sci J 8:121–122PubMedGoogle Scholar
  352. 80.
    Buettner PG, Raasch BA (1998) Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 78:587–593PubMedCrossRefGoogle Scholar
  353. 81.
    Wermoth BM, Fajordo LF (1970) Metastatic basal cell carcinoma: a review. Arch Pathol Lab Med 90:458–462Google Scholar
  354. 82.
    Howles JK (1936) Cancer of the skin in the Negro race. New Orleans Med Surg J 89:143–145Google Scholar
  355. 83.
    White JE, Strudwick WJ, Rickets WAN, Sampson C (1961) Cancer of the skin in Negroes: a review of 31 cases. JAMA 178:845–847PubMedCrossRefGoogle Scholar
  356. 84.
    Davies JNP, Tank R, Meyer R, Thurston P (1968) Cancer of the integumentary tissues in Uganda Africans: the basis for prevention. J Natl Cancer Inst 41:31–51PubMedGoogle Scholar
  357. 85.
    Amonette RA, Kaplan RJ (1978) Squamous cell and basal cell carcinoma in black patients. J Dermatol Surg Oncol 2:158–611Google Scholar
  358. 86.
    Greenbaum SS, Krull EA, Simmons EB (1989) Basal cell carcinoma of the base of the penis in a black patient. J Am Acad Dermatol 20:317–319PubMedCrossRefGoogle Scholar
  359. 87.
    Mora RG, Robins P (1978) Basal cell carcinomas in the center of the face: special diagnostic, prognostic, and therapeutic considerations. J Dermal Surg Oncol 4:315–320Google Scholar
  360. 88.
    Vitasa BC, Taylor HR, Strickland PT (1990) Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 65:2811–2817PubMedCrossRefGoogle Scholar
  361. 89.
    Nguyen AV, Whitaker DE, Frodel J (1993) Differentiation of basal cell carcinoma. Otolaryngol Clin North Am 26:37–56PubMedGoogle Scholar
  362. 90.
    Walther RR, Grossman ME, Troy JL (1981) Basal cell carcinomas on the scalp of a black man many years after epilation by x-rays. J Dermatol Surg Oncol 7:570–571PubMedGoogle Scholar
  363. 91.
    Shore RE, Moseson M, Xue X, Tse Y, Harley N, Pasternack BS (2002) Skin cancer after x-ray treatment for scalp ringworm. Radiat Res 157:410–418PubMedCrossRefGoogle Scholar
  364. 92.
    Parks J Y, Perry EL (1998) Microcystic adnexal carcinoma. Dermatol Surg 24:905–907CrossRefGoogle Scholar
  365. 93.
    Higginson J, Oettle AJ (1960) Cancer incidence in the Banta and “Cape Colored” races of South America: report of a cancer survey in the Transvaal (1953e1955). J Natl Cancer Inst 24:589–671PubMedGoogle Scholar
  366. 94.
    Lanehart WH, Sanusi ID, Misra RP, O'Neal B (1983) Metastasizing basal cell carcinoma in a stasis ulcer in a black woman. Arch Dermatol 119:587–591PubMedCrossRefGoogle Scholar
  367. 95.
    Haber RS, Beltrani VB, Yunakov MJ, Held JL (1989) Basal cell carcinoma of the scalp in a black patient. Cutis 44:59–60PubMedGoogle Scholar
  368. 96.
    Jacyk WK (1999) Xeroderma pigmentosum in black South Africans. Int J Dermatol 38:511–514PubMedCrossRefGoogle Scholar
  369. 97.
    Lambert WC, Kaszica J, Chung H, Moore D (1984) Metastasizing basal cell carcinoma developing in a gunshot wound in a black man. J Surg Oncol 27:97–105PubMedCrossRefGoogle Scholar
  370. 98.
    Ewing MR (1971) The significance of a single injury in the causation of basal cell carcinoma of the skin. Aust NZ J Surg 41:140–714Google Scholar
  371. 99.
    Matsuoka LY, Schauer PK, Sordillo PP (1981) Basal cell carcinoma in black patients. J Am Acad Dermatol 4:670–672PubMedCrossRefGoogle Scholar
  372. 100.
    Woods SG (1995) Basal cell carcinoma in the black population. Int J Dermatol 34:517–518CrossRefGoogle Scholar
  373. 101.
    Kidd MK, Tschen JA, Rosen T, Altman AR, Goldberg L (1989) Carcinoembryonic antigen in basal cell neoplasms in black patients: an immunohistochemical study. J Am Acad Dermatol 21:1007–1010PubMedCrossRefGoogle Scholar
  374. 102.
    Xie J, Johnson RL, Zhang X, Bare JW, Waldman FM, Cogen PH et al (1997) Mutations of the patched gene in sporadic extracutaneous tumors. Cancer Res 57:2369–2372PubMedGoogle Scholar
  375. 103.
    Kulkarni P, Brashear R, Chuang TY (2003) Nevoid basal cell carcinoma syndrome in a person with dark skin. J Am Acad Dermatol 49:332–335PubMedCrossRefGoogle Scholar
  376. 104.
    Martin S, Waisman M (1978) Basal cell nevus syndrome in a black patient: report of a case and review of the literature. Arch Dermatol 114:1356–1357PubMedCrossRefGoogle Scholar
  377. 105.
    Gorlin RJ (1995) Genodermatoses with malignant potential: nevoid basal cell carcinoma syndrome. Dermatol Clin 13:113–125PubMedGoogle Scholar
  378. 106.
    Hinkley GW, Rauschkolb RR (1962) Basal cell epithelioma metastasizing to lymph nodes. Arch Dermatol 86:332–335CrossRefGoogle Scholar
  379. 107.
    Oram Y, Orengo I, Alford E, Green LK, Rosen T, Netscher DT (1994) Basal cell carcinoma of the scalp resulting in spine metastasis in a black patient. J Am Acad Dermatol 31:916–920PubMedCrossRefGoogle Scholar
  380. 108.
    Schwartz RA, DeJager RL, Janniger CK, Lamber WC (1986) Giant basal cell carcinoma with metastases and myelophthisic anemia. J Surg Oncol 33:223–226PubMedCrossRefGoogle Scholar
  381. 109.
    Troyanova P, Danon S, Ivanova T (2002) Nonmelanoma skin cancer and risk of subsequent malignancies: a cancer registry based study in Bulgaria. Neoplasma 49:81–85PubMedGoogle Scholar
  382. 110.
    Frisch M, Melbye M (1995) New primary cancers after squamous cell skin cancer. Am J Epidemiol 41:916–922Google Scholar
  383. 111.
    Rosenberg CA, Greenland P, Khandekar J, Loar A, Ascensao J, Lopez AM (2004) Association of nonmelanoma skin cancer with second malignancy. Cancer 100:130–138PubMedCrossRefGoogle Scholar
  384. 112.
    Norval M (2001) Effects of solar irradiation on the human immune system. In: Giacomoni PU (ed) Sun protection in man. Elsevier, Amsterdam, pp 91–113CrossRefGoogle Scholar
  385. 113.
    Stab F, Hoppe U, Sauermann G (1994) Urocanic acid and its function in endogenous antioxidant defense and UV-protection in human skin (abstract). J Invest Dermatol 102:666Google Scholar
  386. 114.
    Beckstein MS, Windle BH (1996) Basal cell carcinoma in the groin of a black patient with femoral vessel invasion and a second primary malignancy. Plast Reconstr Surg 98:872–875CrossRefGoogle Scholar
  387. 115.
    Burns JE, Eisenhauer ED, Jabaley ME, Cruse JM (1980) Cellular immune deficiency in black patients with basal cell carcinoma. J Surg Oncol 13:129–134PubMedCrossRefGoogle Scholar
  388. 116.
    Bigler C, Feldman J, Hall E, Padilla RS (1996) Pigmented basal cell carcinoma in Hispanics. J Am Acad Dermatol 34:751–752PubMedCrossRefGoogle Scholar
  389. 117.
    Kalter DC, Goldberg LH, Rosen T (1984) Darkly pig-mented lesions in dark-skinned patients. J Dermatol Surg Oncol 10:876–881PubMedGoogle Scholar
  390. 118.
    Roenigk RK, Ratz JL, Bailin PL, Wheeland RG (1986) Trends in the presentation and treatment of basal cell carcinoma. J Dermatol Surg Oncol 12:860–865PubMedGoogle Scholar
  391. 119.
    Miller SJ (1991) Biology of basal cell carcinoma (part I). J Am Acad Dermatol 24:1–13PubMedCrossRefGoogle Scholar
  392. 120.
    Preston DS, Stern RS (1992) Nonmelanoma cancers of the skin. N Engl J Med 327:1649–1662PubMedCrossRefGoogle Scholar
  393. 121.
    Emmett AJJ (1990) Surgical analysis and biologic behavior of 2277 basal cell carcinomas. Aust NZ J Surg 60:855–863CrossRefGoogle Scholar
  394. 122.
    Mora RG, Lee B (1984) Cancer of the skin in blacks I V. a review of nineteen black patients with Kaposi 's sarcoma. J Am Acad Dermatol 11:563–567PubMedCrossRefGoogle Scholar
  395. 123.
    Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi 's sarcoma. Science 266:1865–9186PubMedCrossRefGoogle Scholar
  396. 124.
    Glocker-Reis LA, Miller BA, Hankey BF (1994) SEER cancer statistics review, 1973–1991. National Cancer Institute, Bethesda, MD. National Institutes of Health Publication 94Google Scholar
  397. 125.
    Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoore A et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10–30PubMedCrossRefGoogle Scholar
  398. 126.
    Cress RD, Holly EA (1997) Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California Cancer Registry data, 1988–1993. Cancer Causes Control 8:246–522PubMedCrossRefGoogle Scholar
  399. 127.
    Giraud RM, Rippey E, Rippey JJ (1975) Malignant melanoma of the skin in black Africans. S Afr Med J 49:665–668PubMedGoogle Scholar
  400. 128.
    American Cancer Society (2003) Cancer facts and figures. American Cancer Society, Atlanta, pp 1–52Google Scholar
  401. 129.
    Swan MC, Hudson DA (2003) Malignant melanoma in South Africans of mixed ancestry: a retrospective analysis. Melanoma Res 13:415–419PubMedCrossRefGoogle Scholar
  402. 130.
    Elder DE (1995) Skin cancer: melanoma and other specific nonmelanoma skin cancers. Cancer 75:245–256PubMedCrossRefGoogle Scholar
  403. 131.
    Hudson DA, Krige JE (1995) Melanoma in black South Africans. J Am Coll Surg 180:65–71PubMedGoogle Scholar
  404. 132.
    Vazquez-Botet M, Latoni D, Sanchez JL (1990) Malignant melanoma in Puerto Rico. Biol Assoc Med P R 82:454–457Google Scholar
  405. 133.
    Chen YJ, Wu CY, Chen JT, Shen JL, Chen CC, Wang HC (1999) Clinicopathologic analysis of malignant melanoma in Taiwan. J Am Acad Dermatol 41:945–949PubMedCrossRefGoogle Scholar
  406. 134.
    Bellows CF, Belafsky P, Fortgang IS, Beech DJ (2001) Melanoma in African-Americans: trends in biological behavior and clinical characteristics over two decades. J Surg Oncol 78:10–16PubMedCrossRefGoogle Scholar
  407. 135.
    Miller RW, Rabkin CS (1999) Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 8:153–158PubMedGoogle Scholar
  408. 136.
    Taylor SC (2002) Skin of color: biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol 3:541–562Google Scholar
  409. 137.
    Bergfelt L, Newell GR, Sider JG, Kripke ML (1989) Incidence and anatomic distribution of cutaneous melanoma among United States Hispanics. J Surg Oncol 40:222–226PubMedCrossRefGoogle Scholar
  410. 138.
    Kosary C, Ries L, Miller B (1995) SEER cancer statistics review, 1973–1992: tables and graphs. National Cancer Institute, Bethesda, MDGoogle Scholar
  411. 139.
    Surveillance, Epidemiology, and End Results (SEER) Program ( (2005) Public-Use Data Fast Stats (1992–2001) [Database on CD-ROM]. Bethesda (MD): National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; based on the November 2003 submission. Accessed 1 April 2005
  412. 140.
    Garsaud P, Boisseau-Garsaud AM, Ossundo M, Azaloux H, Escarmant P, Mab GL et al (1998) Epidemiology of melanoma in the French West Indies (Martinique), 1998. Am J Epidemiol 147:66–68PubMedCrossRefGoogle Scholar
  413. 141.
    Black WC, Goldhahn RT, Wiggins C (1987) Melanoma within a southwestern Hispanic population. Arch Dermatol 123:1331–4133PubMedCrossRefGoogle Scholar
  414. 142.
    Pathak DR, Samet JM, Howard CA, Key CR (1982) Malignant melanoma of the skin in New Mexico 1969–1977. Cancer 50:1440–1446PubMedCrossRefGoogle Scholar
  415. 143.
    Trapido EJ, Burciaga-Valdez R, Obeso JL, Strickman-Stein N, Rotger A, Perez-Stable EJ (1995) Epidemiology of cancer among Hispanics in the United States. J Natl Cancer Inst Monogr 18:17–28PubMedGoogle Scholar
  416. 144.
    Rhodes AR, Weinstock MA, Fitzpatrick TB, Mihm MC Jr, Sober AJ (1987) Risk factors for cutaneous melanoma: a practical method of recognizing predisposed individuals. JAMA 258:3146–3154PubMedCrossRefGoogle Scholar
  417. 145.
    Waterhouse J, Correa P, Muir C, Powel J (eds) (1976) Cancer incidence in five continents, vol. 4. International Agency for Research in Cancer, LyonGoogle Scholar
  418. 146.
    Tanaka N, Amagasa T, Iwaki H (1994) Oral malignant melanoma in Japan. Oral Surg Oral Med Oral Pathol 78:81–90PubMedCrossRefGoogle Scholar
  419. 147.
    Swerdlow AJ (1990) International trends in cutaneous melanoma. In: Davis DL, Hoel D (eds) Trends in cancer mortality in industrial countries, vol 609. New York Academy of Sciences, New York, pp 235–251Google Scholar
  420. 148.
    Stern RS (1999) The mysteries of geographic variability in non-melanoma skin cancer incidence. Arch Dermatol 135:843–484PubMedCrossRefGoogle Scholar
  421. 149.
    Krishnamurthy S, Yeole B, Joshi S, Gujarathi M, Jussawalla DJ (1994) The descriptive epidemiology and trends in incidence of non-ocular malignant melanoma in Bombay and India. Indian J Cancer 31:64–71PubMedGoogle Scholar
  422. 150.
    Reintgen DS, McCarty KM, Cox E, Seigler HF (1982) Malignant melanoma in black American and white American populations: a comparative review. JAMA 248:1856–1859PubMedCrossRefGoogle Scholar
  423. 151.
    Krementz ET, Sutherland CM, Carter RD (1976) Malignant melanoma in the American black. Ann Surg 5:533–542CrossRefGoogle Scholar
  424. 152.
    Ishihara K, Ikeda S, Arao T, Mori S, Ohura T, Takahashi M et al (1989) Prognostic factors for malignant melanoma in Japanese. Skin Cancer 4:349–360CrossRefGoogle Scholar
  425. 153.
    Holly E, Ashton D, Ahn D, Kristiansen J (1995) Cutaneous melanoma in women: exposure to sunlight, ability to tan, and other UV related risk factors. Am J Epidemiol 141:923–933PubMedGoogle Scholar
  426. 154.
    Whiteman DC, Whiteman CA, Green AC (2001) Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 12:69–82PubMedCrossRefGoogle Scholar
  427. 155.
    Elwood JM (1996) Melanoma and sun exposure. Semin Oncol 23:650–666PubMedGoogle Scholar
  428. 156.
    Coleman WP, Gately LE, Krementz AB (1980) Nevi, lentigi-nes, and melanoma in blacks. Arch Dermatol 116:548–551PubMedCrossRefGoogle Scholar
  429. 157.
    McCredie M, Coates MS, Ford JM (1990) Cancer incidence in migrants to New South Wales from England, Wales, Scotland and Ireland. Br J Cancer 62:3992–3996CrossRefGoogle Scholar
  430. 158.
    Cooke KR, Fraser J (1985) Migration and death from malignant melanoma. Int J Cancer 36:175–817PubMedCrossRefGoogle Scholar
  431. 159.
    Titus-Ernstoff L (2000) An overview of the epidemiology of cutaneous melanoma. Clin Plast Surg 27:305–316PubMedGoogle Scholar
  432. 160.
    Byrd KM, Wilson DC, Hoyler SS (2004) Advanced presentation of melanoma in African Americans. J Am Acad Dermatol 50:142–143CrossRefGoogle Scholar
  433. 161.
    Muchmore JH, Mizuguchi RS, Lee C (1996) Malignant melanoma in American black females: an unusual distribution of primary sites. J Am Coll Surg 183:457–465PubMedGoogle Scholar
  434. 162.
    Collins RJ (1984) Melanoma in the Chinese of Hong Kong: emphasis on volar and subungual sites. Cancer 54:1482–8148PubMedCrossRefGoogle Scholar
  435. 163.
    Seiji M, Takahashi M (1982) Acral melanoma in Japan. Hum Pathol 13:607–609PubMedCrossRefGoogle Scholar
  436. 164.
    Hinds MW (1979) Anatomic distribution of malignant melanoma of the skin among non-Caucasians in Hawaii. Br J Cancer 40:497–499PubMedCrossRefGoogle Scholar
  437. 165.
    Pantangeo EE, Canlas M, Basa G, Sin R (1963) Observations in the incidence, biology, and pathology of skin cancer among Filipinos. Natl Cancer Inst Monogr 10:109–125Google Scholar
  438. 166.
    Pringgoutomomo S (1963) Skin cancer in Indonesia. Natl Cancer Inst Monogr 10:191–195Google Scholar
  439. 167.
    Johnson DS, Yamane S, Morita S, Yonehara C, Wong J (2003) Malignant melanoma in non-Caucasians: experience from Hawaii. Surg Clin N Am 83:275–282PubMedCrossRefGoogle Scholar
  440. 168.
    O'Leary JA, Berend KR, Johnson JL, Levin LS, Seigler HF (2000) Subungual melanoma. Clin Orthop Relat Res 378:206–122PubMedCrossRefGoogle Scholar
  441. 169.
    Pantoja E, Llobet RE, Roswit B (1976) Melanomas of the lower extremity among native Puerto Ricans. Cancer 38:1420–3142PubMedCrossRefGoogle Scholar
  442. 170.
    Black WC, Palmer C, Varsa E, Bartow JA, Fovcar E, Burgdorf WH (1987) The New Mexico Melanoma Registry: a model of a statewide cooperative program. Am J Dermatopathol 9:10–14PubMedCrossRefGoogle Scholar
  443. 171.
    Rahman Z, Taylor SC (2001) Malignant melanoma in African Americans. Cutis 67:403–406PubMedGoogle Scholar
  444. 172.
    Hudson DA, Krige JE, Stubbings H (1998) Plantar melanoma: results of treatment in three population groups. Surgery 124:877–882PubMedCrossRefGoogle Scholar
  445. 173.
    Pitche P, Napo-Koura G, Kpodzro K, Tchangai-Wall K (1996) Melanoma in Togo: a retrospective study over 20 years. Ann Dermatol Venereol 123:786–788PubMedGoogle Scholar
  446. 174.
    Vayer A, Lefor AT (1993) Cutaneous melanoma in African Americans. South Med J 86:181–182PubMedCrossRefGoogle Scholar
  447. 175.
    Rippey JJ, Rippey E (1984) Epidemiology of malignant melanoma of the skin in South Africa. S Afr Med J 65:595–598PubMedGoogle Scholar
  448. 176.
    Kukita A, Ishihara K (1989) Clinical features and distribution of malignant melanoma and pigmented nevi on the soles of the feet in Japan. J Invest Dermatol 92:2105–2135CrossRefGoogle Scholar
  449. 177.
    Kato T, Suetake T, Tabata N (1999) Epidemiology and prognosis of plantar melanoma in 62 Japanese patients over a 28 year period. Int J Cancer 38:515–519Google Scholar
  450. 178.
    Feun LG, Raub WA Jr, Duncan RC (1994) Melanoma in a southeastern Hispanic population. Cancer Detect Prev 18:145–512PubMedGoogle Scholar
  451. 179.
    Stevens NG, Liff JM, Weiss NS (1990) Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Int J Cancer 45:691–369PubMedCrossRefGoogle Scholar
  452. 180.
    Coleman WP, Loria PR, Reed RJ, Krementz ET (1980) Acral lentiginous melanoma. Arch Dermatol 116:773–677PubMedCrossRefGoogle Scholar
  453. 181.
    Wong TY, Ohara K, Kawashima M, Sober AJ, Nogita T, Mihm MC Jr (1996) Acral lentiginous melanoma (including in-situ melanoma) arising in association with naevocel-lular naevi. Melanoma Res 6:241–246PubMedCrossRefGoogle Scholar
  454. 182.
    Slingluff CL, Vollmer R, Seigler HF (1990) Acral melanoma: a review of 185 patients with identification of prognostic variables. J Surg Oncol 45:91–98PubMedCrossRefGoogle Scholar
  455. 183.
    Sutherland CM, Mather FJ, Muchmore JH, Carter RD, Reed RJ, Krementz ET (1993) Acral lentiginous melanoma. Am J Surg 166:64–67PubMedCrossRefGoogle Scholar
  456. 184.
    Patterson RH, Helwig EB (1980) Subungual melanoma: a clinicopathologic study of 125 primary cutaneous melanomas. Cancer 46:2492–2540CrossRefGoogle Scholar
  457. 185.
    Feibleman CE, Stoll M, Maize JC (1980) Melanomas of the palm, sole, and nail bed: a clinicopathologic study. Cancer 46:2492–5204PubMedCrossRefGoogle Scholar
  458. 186.
    Gloster HM Jr (1996) Dermatofibrosarcoma protuberans. J Am Acad Dermatol 35:355–374PubMedCrossRefGoogle Scholar
  459. 187.
    Garg SK, Subbuswamy SG, Alabi JO, Lawrie JH (1978) Der-matofibrosarcoma protuberans in northern Algeria: a clinico-pathological review of 17 cases. Clin Oncol 4:113–122PubMedGoogle Scholar
  460. 188.
    Dupree WB, Langloss JM, Weiss SW (1985) Pigmented dermatofibrosarcoma protuberans (Bednar tumor): a pathologic, ultrastructural, and immunohistochemical study. Am J Surg Pathol 9:630–639PubMedCrossRefGoogle Scholar
  461. 189.
    DiGiovanna JJ, Safai B (1981) Kaposi 's sarcoma: retrospective study of 90 cases with particular emphasis on the familial occurrence, ethnic background and prevalence of other diseases. Am J Med 71:779–783PubMedCrossRefGoogle Scholar
  462. 190.
    Laor Y, Schwartz RA (1979) Epidemiologic aspects of American Kaposi 's sarcoma. J Surg Oncol 12:299–303PubMedCrossRefGoogle Scholar
  463. 191.
    Isaacson C (1979) Cancer of the skin in urban blacks of South Africa. Br J Dermatol 100:347–350PubMedCrossRefGoogle Scholar
  464. 192.
    Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ (2002) Cancer surveillance series: trends in Kaposi 's sarcoma and non-Hodgkin 's lymphoma incidence in the United States from 1973–1998. J Natl Cancer Inst 16:1204–1210CrossRefGoogle Scholar
  465. 193.
    Lennette ET, Blackbourn DJ, Levy JA (1996) Antibodies to human herpes virus type 8 in the general population and in Kaposi 's sarcoma patients. Lancet 348:858–861PubMedCrossRefGoogle Scholar
  466. 194.
    Greenblatt RM, Jacobson L P, Levine AM, Melnick S, Anastos K, Cohen M et al (2001) Human herpes virus 8 infection and Kaposi 's sarcoma among human immunodeficiency virus-infected and uninfected women. J Infect Dis 183:1130–1134PubMedCrossRefGoogle Scholar
  467. 195.
    Akaraphanth R, Douglass MC, Lim HW (2000) Hypopigmented mycosis fungoides: treatment and a 6½ year follow-up of 9 patients. J Am Acad Dermatol 42:33–39PubMedCrossRefGoogle Scholar
  468. 196.
    Weinstock MA, Horm JW (1988) Mycosis fungoides in the United States: increasing incidence and descriptive epidemiology. JAMA 260:42–46PubMedCrossRefGoogle Scholar
  469. 197.
    Weinstock MA, Gardstein B (1999) Twenty-year trends in the reported Incidence of mycosis fungoides and associated mortality. Am J Public Health 89(8):1240–4PubMedCrossRefGoogle Scholar
  470. 198.
    Stone MC, Styles AR, Cockerell CJ (2001) Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature. Cutis 67:133–138PubMedGoogle Scholar
  471. 199.
    Lambroza E, Cohen SR, Phelps R, Lebwohl M, Braverman IM, Dicostanzo D (1995) Hypopigmented variant of mycosis fungoides: demography, histopathology, and treatment of seven cases. J Am Acad Dermatol 32:987–993PubMedCrossRefGoogle Scholar
  472. 200.
    Whitmore SE, Simmons-O'Brien E, Rotter FS (1994) Hypopigmented mycosis fungoides. Arch Dermatol 130:476–480PubMedCrossRefGoogle Scholar
  473. 201.
    Braverman IM (1991) Cutaneous T-cell lymphoma. Curr Probl Dermatol 3:184–227CrossRefGoogle Scholar
  474. 202.
    Dekio S, Funaki M, Jidoi J, Mihara M (1994) Trichilemmal carcinoma on the thigh: report of a case. J Dermatol 21:494–649PubMedGoogle Scholar
  475. 203.
    Laochumroonvorapong P, Kokta V, Quan MB (2002) Trichilemmal carcinoma in an African American. Dermatol Surg 28:284–628PubMedCrossRefGoogle Scholar
  476. 204.
    Anderson LL, Phipps TJ, McCollough ML (1992) Neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in a black. J Dermatol Surg Oncol 18:375–380PubMedGoogle Scholar
  477. 205.
    Simstein NL, Soluggs NK (1998) Merkel cell tumor: two cases. Int Surg 83:60–62PubMedGoogle Scholar
  478. 206.
    Ohtsuka H, Nagamatsu S (2002) Microcystic adnexal carcinoma: review of 51 Japanese patients. Dermatology 204:190–193PubMedCrossRefGoogle Scholar
  479. 207.
    Peterson CM, Ratz JL, Sangueza OP (2001) Microcystic adnexal carcinoma: first reported case in an African American man. J Am Acad Dermatol 45:283–285PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • M. Ulrich
  • C. Ulrich
    • 1
  • Anja V. Potthoff
    • 2
  • Norbert H. Brockmeyer
  • Competence Network for HIV/AIDS Germany
  • G. Schäfer-Hesterberg
    • 3
  • Theodore Rosen
  • Robert Baran
    • 4
  • Kenneth W. NealJr
    • 5
  • Hugh M. GlosterJr
  1. 1.Department of Dermatology, Transplant-Aftercare UnitCharité University Hospital BerlinBerlinGermany
  2. 2.Department of DermatologySt. Josef Hospital, Ruhr-University BochumBochumGermany
  3. 3.Department of Dermatology, Venerology and AllergologyCharité Universty Hospital Berlin, Skin Cancer Center CharitéBerlinGermany
  4. 4.Nail Disease CentreCannesFrance
  5. 5.Washington Dermatology ConsultantsUSA

Personalised recommendations